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Abstract 
 
The relationship between cardiovascular disease and hearing loss has already been 
proven. However literature does not provide information on the prevalence of 
hearing loss in adults with cardiovascular disease. Previous studies provide 
contradictory information regarding the audiological characteristics in this 
population. Data relating to the South African context is minimal. The objectives 
of this descriptive survey research study were to describe the prevalence of 
hearing loss in adults with this cardiovascular disease and determine the variables 
which may influence hearing thresholds in this population. Ninety two individuals 
diagnosed with coronary artery disease or cardiomyopathy were recruited using a 
non-probability, purposive sampling strategy. This sample, with an average age of 
48 years and five months, consisted of more males than females and more 
participants with coronary artery disease than cardiomyopathy. Participants 
underwent a comprehensive audiological evaluation including an otoscopic 
examination, immittance audiometry, pure-tone audiometry, speech audiometry, 
as well as distortion product otoacoustic emissions. Content analysis, descriptive 
statistics, t-tests and an analysis of covariance revealed a hearing loss prevalence 
of 5%. These participants presented with a low frequency sensorineural hearing 
loss with the right ear being more affected. It was found that duration of 
cardiovascular disease influenced hearing thresholds. Implications of this study 
include the importance of prevention and early identification of hearing loss. This 
highlights the need to establish the role of audiologists within a multi-disciplinary 
team and the management of individuals with this disease. 
 
Key words: audiological evaluation, cardiomyopathy, cardiovascular disease, coronary 
artery disease, hearing loss 
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CHAPTER 1 
 
INTRODUCTION 
 
This chapter provides a brief background on hearing loss in adults with cardiovascular 
disease. It also discusses the rationale for this study and provides an outline of the 
chapters which follow. 
1.1 Background 
Cardiovascular disease is an umbrella term used to describe many different types 
of heart diseases. The two most prevalent forms of cardiovascular disease are coronary 
artery disease and cardiomyopathy. 
It is widely accepted that cardiovascular diseases are a significant contributor to 
the global burden of chronic diseases and is reported to be the number one cause of death 
globally (Reddy et al., 2006; World Health Organization, 2008). In 2005, the World 
Health Organization estimated that 36.9 per 1000 males and 22.3 per 1000 females 
present with cardiovascular disease, of which 80% live in developing countries (Arnold et 
al. 2005). Data on the prevalence of cardiovascular disease in South Africa is limited; 
however, a study conducted in rural Limpopo revealed a high prevalence of 
cardiovascular disease (Alberts, et al., 2005). It has been suggested many rural 
communities are exposed to similar, significant risk factors known to cause 
cardiovascular disease. An increase in risk factors almost always results in the heart being 
unable to perform its function optimally. 
The heart performs the crucial function of enabling blood supply to all the parts of 
the body (Lawless, 2010). Any dysfunction or abnormality of the heart is therefore likely 
to impact on the entire body (Lawless, 2010). These effects include fatigue, reduced 
mobility in the limbs, some degree of failure in the functioning of major organs such as 
the liver and lungs. There is also evidence of some degree of disruption in the functioning 
of other organs such as the ear (D’Adamo, 2005; Cruickshanks, et al., 1998).  
Cardiovascular disease may also impact on the human auditory system 
(Cruickshanks, et al., 1998). The cochlea is situated in the inner ear and is responsible for 
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converting sound vibrations into action potentials which can then be transmitted to the 
auditory cortex for interpretation (Zhen, Shen, He, Long, Madison, & Dallos, 2000). The 
stria vascularis in the cochlea have a large capillary blood flow. A decrease in the blood 
supply to the cochlea as a result of cardiovascular disease may result in cochlear 
degeneration and will disrupt the physical and chemical processes in the cochlea 
(Schuknecht & Gacek, 1993). This, in turn, may lead to a hearing impairment (Torre, 
Cruickshanks, Klein, Klein, & Nondhal, 2005). 
Research regarding the prevalence of hearing loss in individuals with 
cardiovascular disease was first described in the 1960’s (Rosen & Olin 1965; Spencer, 
1973). At the time, many studies reported an association between cardiovascular disease 
and hearing loss; however, some researchers disagreed (Miller & Ort, 1965; Drettner, 
Hedstrand, & Klockhoff, 1975). Researchers continued to delve into the association 
between cardiovascular disease and hearing loss for the next few decades and by the 
1990’s research confirmed this association and began investigating the nature of hearing 
loss in cardiovascular disease (Rubinstein, Hildesheimrt, Zohar, & Chilarovitz, 1977; 
Susmano & Rosenbush, 1988; Gates, Cobb, D’Agostino, & Wolf, 1993; Brant, Gordon-
Salant, Pearson, Klein, Morrell, Metter, & Fozard, 1996). 
Previous studies have attempted to describe the audiological characteristics of 
adults with cardiovascular disease, but contradictory results have been reported (Gates et 
al., 1993; Pratt, Kuller, Talbott, McHugh-Pemu, Buhari, & Xu, 2009). This has resulted 
in many gaps in the understanding of this disease in relation to its impact on hearing loss 
in adults. Studies have also aimed to determine which variables influence hearing 
thresholds in this population. From the numerous studies, age and gender were found to 
have an effect on hearing thresholds in adults with cardiovascular disease (Pratt et al., 
2009; Torre et al., 2005). 
Previous studies have also provided limited information on the influence of 
cardiovascular disease on hearing thresholds since many of them were conducted on the 
geriatric population only (presbycusis was not excluded). Furthermore, these studies 
cannot be generalized to the South African context. Because there are no published 
studies on hearing loss in cardiovascular disease in South Africa, there is a lack of 
information regarding the percentage of individuals with this disease who present with a 
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hearing loss and the nature of this hearing loss. This study therefore aimed to determine 
the prevalence of hearing loss in adults with cardiovascular disease and to determine if 
age, gender, diagnosis and/or duration of cardiovascular disease influence hearing 
thresholds in this population. 
1.2 Chapter Outline 
The study consists of six chapters and appendices. The first chapter provides a 
brief background on cardiovascular disease and its impact on hearing in the adult 
population. It also includes the rationale of the study and outlines the content of each 
chapter in the study 
The literature review (chapter two) defines the term cardiovascular disease and 
focuses on the prevalence of cardiovascular disease in developed and developing 
countries. The prevalence of hearing loss and the effect of this disease on the auditory 
system are also presented in relation to previous studies along with possible variables 
which may influence hearing thresholds in this population. 
The methodology of the study is outlined in chapter three. It discusses the phases 
of the research process, describes the instrumentation and procedures utilized to obtain 
data and considerations regarding reliability and validity. It further includes the ethical 
considerations and the rights of the participants in the study. This chapter also outlines 
the methods of statistical analysis and the parametric measure utilized during the study. 
Chapter four presents the results in relation to the aims of the study. It describes 
the audiological findings, after which it determines the prevalence of hearing loss in 
adults with cardiovascular disease. The influence of the independent variables is 
discussed and the results of parametric measures are highlighted. 
The discussion chapter (chapter five) provides a summary of the audiological 
findings and briefly discusses the influence of independent variables on hearing 
thresholds in this population. The greater part of the chapter focuses on the prevalence of 
hearing loss found in this study in relation to that of the general population, previous 
studies and other disorders. 
Chapter six concludes the study by providing a brief outline of the results of the 
study and states the strengths of the study and its weaknesses. It further provides 
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recommendations for future research and the implications of the results in a clinical 
setting. 
Lastly, the appendices provide valuable information regarding the tools utilized 
during the data collection and the data recording process. This is important for the 
replication of the study. 
1.3 Conclusion 
This chapter discussed the term cardiovascular disease and provided statistics on the 
prevalence of this disease. It also briefly described the effect of cardiovascular disease on 
the auditory system and previous research which has focused on this determining an 
association between the two. The variables which may influence hearing thresholds of 
adults with cardiovascular disease were also discussed and, by highlighting the gaps in 
previous studies, summarizes the rationale for this study. Furthermore, an outline of the 
chapters which follow was also provided. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
This chapter defines the term cardiovascular disease and focuses on the 
prevalence of this disease in developing and developed countries. This chapter also 
discusses the effect of this disease on the auditory system by analyzing the previous 
studies and describing the role of the audiologist in this population  
2.1 Cardiovascular Disease 
Cardiovascular disease is defined as a class of diseases that involve the heart and 
blood vessels (arteries and veins) (Maton, 1993; Rosendorff, 2005). Technically, the term 
refers to any disease which affects the cardiovascular system. Cardiovascular disease, an 
umbrella term, encompasses a wide range of conditions such as coronary artery disease, 
myocardial infarction, angina pectoris, atrial fibrillation, congestive heart failure, stroke, 
transient ischemic attack, carotid endarterectomy and congenital heart disease (Pratt et 
al., 2009).  
The most common types of the disease are coronary artery disease and 
cardiomyopathy (National Heart, Lung & Blood Institute, 2007). Coronary artery disease, 
also known as coronary heart disease, is an abnormality of the arteries which supply 
blood, oxygen and nutrients to the heart (Resink, Phillippova, Joshi, Kyriakakis, & Erne, 
2007). This is usually caused by atherosclerosis, which is the process whereby a build-up 
of fatty deposits, plaque, collagen, proteins and/or excess smooth muscle cells cause a 
narrowing in the arteries to the heart (Suri, Kathuria, & Molinari, 2011; Balch, Stengler, 
& Balch, 2008). An abnormality or constriction in the arteries to the heart can trigger an 
injury and may lead to some of the following symptoms: chest pain, shortness of breath, 
heaviness in the chest, dizziness, profuse sweating, nausea and/or vomiting (American 
Heart Association, n. d.). 
Cardiomyopathy is characterized by the deterioration in the anatomy and/or the 
function of the myocardium (Trio, de Gregorio, & Ando, 2010; Schultheiss & Kuhl, 
1997). The myocardium is a thick, muscular layer forming the wall of the heart. It is 
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composed of cardiac muscle fibres and is responsible for the contraction of the heart 
(Holubarsch, 2002). The myocardium may become weak, inflamed or it may lose its 
ability to circulate blood, resulting in reduced blood flow in the body. Cardiomyopathy 
may result in arrhythmia, heart murmur, shortness of breath and/or chest pain (National 
Heart, Lung & Blood Institute, 2007).  
The causes of cardiovascular disease are numerous and include hypertension, high 
blood cholesterol, diabetes, obesity, smoking and genetic conditions (Shah, 2006; Joshi et 
al., 2009). The World Health Organization reported an increase in risk factors due to 
lifestyle changes which are, in turn, causing cardiovascular disease (Mackay, Mensah, 
Mendis, & Greenlund, 2007). These lifestyle changes included physical inactivity, poor 
diet (due to the increased consumption of processed foods) and an increase in smoking 
(Machay et al., 2007). 
The prognosis of cardiovascular disease is dependent on numerous factors 
including: age of onset, early identification, type of treatment and the lifestyle 
modifications after diagnosis (Kapoor & Singh, 1993). Females reportedly have a poorer 
prognosis than males (Wilkinson & Cockcroft, 1999). Psychosocial factors, depression, 
socio-economic status and social support also influence prognosis and they are powerful 
motivating factors in the recovery process (Yusuf, Cairns, Camm, Fallen, & Gersh, 
2010). 
2.2 Prevalence of Cardiovascular Disease 
It has been reported that “Cardiovascular diseases are a major contributor to the 
global burden of chronic diseases with 29.3% of global deaths and 9.9% of total disease 
burden being attributed to cardiovascular disease” (Reddy et al., 2006, p. 461). This is 
confirmed by the World Health Organization who reported that cardiovascular diseases 
are the number one cause of death globally (World Health Organization, 2008). 
The statistics on the prevalence of the disease in developed countries and 
developing countries appear to be contradictory. A developed country is a country which 
is considered to have an advanced economy, is highly industrialized and its citizens have 
a high standard of living (O’Sullivan & Sheffrin, 2003). The International Monetary Fund 
(2011) reported the following countries (amongst others) to be classified as developed 
countries: Australia, Belgium, Canada, Germany, Sweden, and the United States of 
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America. A developing country is defined as a country of low to middle income, average 
standard of living and in the process of industrialization (O’Sullivan & Sheffrin, 2003). 
Some of the following countries are classified as developing countries: Algeria, 
Bangladesh, Brazil, Pakistan, Columbia, South Africa, Sri Lanka and Sierra Leone 
(International Monetary Fund, 2011).  
In developed countries, the prevalence of cardiovascular disease is reported to 
range between 6% and 23% (Australian Bureau of Statistics, 2006). It has been reported 
that in the United States of America, an estimated 81,100,000 American adults have one 
or more type of cardiovascular disease (Lloyd-Jones et al., 2010). In Australia, the 
prevalence of cardiovascular disease was reportedly 18% in 2004-2005 (Australian 
Bureau of Statistics, 2006). Independent studies conducted in Germany and Ontario, 
Canada, revealed an increase of the disease in adults due to an increase in the associated 
risk factors in adolescents (Flouris, Canham, Faught, & Klentrou, 2007; Muller-
Riemenschneider, Nocon, & Willich, 2010). 
The World Health Organization (2008) reported that cardiovascular diseases are 
the number one cause of death globally with low- and middle income countries 
disproportionately affected. Recent research has indicated that developing countries 
contribute in excess of 70% of the global burden of this disease (Lopez 1993; Whelton, 
Brancati, Appel, & Klag, 1995). 
While developing countries are reportedly disproportionately affected, data on the 
prevalence of cardiovascular disease in developing countries have been marked with 
complications. Statistics on the prevalence of cardiovascular disease have been limited 
and may not always be accurate.  
Studies conducted between the 1960s and 1980s have provided valuable statistical 
data regarding the prevalence of cardiovascular disease in low income, developing 
countries like sub-Saharan Africa. These studies reported an increase in the prevalence on 
non-communicable diseases such as cardiovascular disease globally (Yack, Hawkes, 
Gould, & Hofman, 2004). Table 1 provides a summary of data which has been compiled 
and studies which have been conducted on the prevalence of cardiovascular disease in 
some developing regions. 
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Table 1 
Summary of the Prevalence of Cardiovascular Disease in Developing Countries 
Country/Region Authors Conclusion regarding the Prevalence of CVD 
Joshi et al. (2009) 
-An increase in disease burden attributed to CVD 
-An increase in CVD in young adults 
Prabhakaran et al. (2005) In Delhi: 7.3% 
Mohan et al. (2001) In Chennai: 11%. 
India 
 
Reddy et al. (2006) 
An increase in the incidence of CVD (especially in the 
industrial population) 
Middle East 
Motlagh, O’Donnell, & 
Yusuf (2009) 
An increase in the number of CVD cases been seen in 
recent years. 
Bhopal et al. (1999) 
South Asians are reported to have the highest rated of 
Coronary Heart Disease. 
Pakistan 
 
Dodani et al. (2004) 
An increase in the prevalence of CVD, especially in 
the urban population. There is a great need for 
increased awareness and prevention programs. 
Costa Rica Monge & Beita (2000) 
An increase in the prevalence of CVD in adults 
between 20-40 years and 70% in the prevalence of 
CVD risk factors in adolescents. Prevalence of CVD is 
higher in urban areas. There is a need for prevention 
measures, especially in young adults. 
West Indies Miller et al. (1989) 
In 1989, incidence of CVD in people of African origin 
was 0.68% and 0.54% among men and women 
respectively. Analysis of risk factors at the times 
revealed an expected increase in CVD in the future. 
 
Akinboboye et al. (2003) 
CVD rates are relatively low compared to rates of the 
Western countries. In 1990, the burden of CVD was 
4.5 million 
Muna (1993) 
The prevalence of CVD in Sub-Saharan Africa is 
increasing. 
Akinboboye et al. (2003) 
Very low CVD prevalence rates were reported in 
Kenya, Uganda and Kampala. 
Akinboboye et al. (2003) 
A low prevalence of CVD in Nigeria, Ghana & Cote 
d’Ivoire between 1960 and1979, averaging 2%. 
Africa: 
-Sub-Saharan 
Africa 
 
 
 
-East Africa 
 
-West Africa 
 
-Central Africa Mets (1993) A Prevalence of approximately 1% in Rwanda. 
Seedat et al. (1992) 
Prevalence of CAD in Durban in 1986 is 
approximately 2.4%. 
Seftel & Kew (1970) 
Prevalence rate of CAD in 1970 in Johannesburg 
General Hospital was 0.6%. 
Schrire (1971) 
CAD prevalence rate of 1.4% in the black population 
in Cape Town in 1970. 
Steyn (2007 
Current rates of prevalence of CVD are unknown. 
Akinboboye et al. (2003) 
Increasing prevalence of CVD over the years. 
Alberts et al. (2005) 
High Prevalence of CVD in rural black populations in 
Limpopo. 
South Africa 
Sliwa et al. (2008) 
The prevalence of CVD risk factors was extremely 
high in urban African communities in Soweto. 
Note. CVD=Cardiovascular disease; CAD=Coronary artery disease 
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Overall, reports from East, West and Central Africa have shown similar 
prevalence rates (Muna, 1993). The prevalence rates in Africa and the West Indies appear 
to be lower than that of developing countries; however, the prevalence rate in India 
appears to be similar to that of the United States of America. Whilst the prevalence rates 
in Table 1 are comparatively lower than those of Western countries including Europe, the 
context in which the prevalence rates in Table 1 were obtained needs to be taken into 
account. In many developing countries deaths were not always registered and autopsies 
were not conducted unless deemed necessary. Furthermore, medical intervention is not 
always accessible and therefore cases are not always reported. These factors may be 
contributing to the contradiction in statistics between recent studies and the statistics 
provided by the World Health Organisation. 
The prevalence rate of cardiovascular disease in developing countries appeared to 
be highest in Asia and in South America. Africa appeared to present with the lowest 
prevalence rates of the disease. Many studies were unable to provide prevalence rates 
thereby highlighting the need for further research in this disease. Africa has the lowest 
output in the world of cardiovascular research (Rosmarakis et al., 2005). Statistics for the 
prevalence of cardiovascular disease in developing countries, especially Africa, are 
therefore rare. Data from the 1960s onward consisted largely of hospital records and 
autopsies conducted. These may not be an accurate reflection of the prevalence of this 
disease in society. It has, however, been ascertained that the number of individuals at risk 
for the disease and the incidence of reported cases is increasing each year (Dahlof, 2009). 
In South Africa, the prevalence of cardiovascular disease is unknown (Steyn, 
2007). Data on the number of heart attacks South Africans suffer do not exist; however, 
given the limited information available on mortality rates, it can be roughly estimated that 
approximately 130 heart attacks occur daily in South Africa (Steyn, 2007). This estimate 
does not include other forms of cardiovascular diseases. A study conducted in Limpopo 
revealed that there is a high prevalence of cardiovascular disease in the rural black 
population in that area (Alberts et al., 2005). The results from this study cannot be 
generalized to other communities in rural areas, although it has been suggested that many 
rural communities in South Africa are exposed to similar, significant levels of risk factors 
which could cause this disease. 
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A study conducted in the heart of Soweto at Chris Hani Baragwanath Hospital 
focused on understanding the characteristic burden imposed by heart disease in an urban 
African community (Sliwa et al., 2008). The study (n = 4164) found that heart failure (for 
example, cardiomyopathy) was found to be most common (44% of participants). The 
prevalence of risk factors for the disease in that population was also found to be 
extremely high. 
The aforementioned studies have also provided prevalence rates of cardiovascular 
disease on various variables (such as, age and gender). Cardiovascular disease has 
generally been associated with the geriatric population; however, the increase in early age 
of onset of the disease globally appears to be causing considerable alarm. It has been 
estimated that 40-50% of reported cases of this condition are below the age of 70 years 
(Reddy & Yusuf, 1998), but this appears to be changing. Recent studies have indicated 
that, for approximately 25% of reported cases, the age of onset appears to be below 40 
years (Sreeraman, 2008). 
A study conducted in Finland (a developed country) on the adult population 
revealed that the arteries began to demonstrate some form of abnormality between the 
ages of 33 and 39 years of age (Raitakari et al., 2003). In 2009, the American Heart 
Association reported an estimated 81,100,000 American adults to have one or more types 
of the disease, of which more than 50% were below the age of 60 years (Llyod-Jones et 
al., 2010). Another study conducted on American adolescents revealed an increase in the 
prevalence of risk factors for the disease in the youth (Rodriguez et al., 2006). Similarly, 
the Australian Bureau of Statistics (2006) reported that the prevalence of cardiovascular 
disease in Australia increased with age in 2004-2005, 13% in individuals between 35 and 
44 years and 23% in individuals between 45-54 years.  
A study conducted in India revealed that the age of onset of cardiovascular 
disease in the industrial population in India is becoming lower (Reddy et al., 2006). This 
was attributed to lifestyle changes, dietary changes and an increase in risk factors. The 
aforementioned studies dispel the long believed notion that this disease is associated with 
the geriatric population only. They also highlighted the need for medical intervention in 
this high risk population (for example, screening programmes, and increased awareness). 
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Another variable which may influence the prevalence of cardiovascular disease is 
gender. Studies conducted in the 1980s and 1990’s have indicated that the disease occurs 
primarily in males; however, recent studies have indicated an increased prevalence in 
females in recent years, possibly attributed to lifestyle changes. In 2005, the World 
Health Organisation estimated that 36.9 per 1000 males and 22.3 per 1000 females 
present with the disease (Arnold et al., 2005). In Australia, overall, the prevalence of 
cardiovascular disease in females was 20% compared to 16% for males (Australian 
Bureau of Statistics, 2006). 
A study conducted in Limpopo revealed one fifth of females and one third of 
males in that community to have a high risk for suffering from a cardiovascular event in 
the next ten years (Alberts et al., 2005). The results from this study cannot be generalized 
to other black communities in rural areas, although it has been suggested that many rural 
communities in South Africa are exposed to similar, significant levels of risk factors 
which could cause this disease. Sliwa et al. (2008) found more females to present with 
heart failure than males in Soweto. The similarity of these findings allow for the 
conclusion that gender may be influencing the prevalence rate of cardiovascular disease 
in recent years. 
2.3 Effects of Cardiovascular Disease 
The heart is a central organ in the body and performs a crucial function (Lawless, 
2010). It is responsible for transporting oxygen and nutrients to the organs of the body 
and for carrying carbon dioxide and waste products away from the body organs (Gersh, 
2000). The symptoms of coronary artery disease and cardiomyopathy may act as warning 
signs preceding a cardiovascular event (Engstrom, Melander, & Hedblad, 2010). 
It has however been reported that cardiovascular disease affects the entire body in 
many different ways prior to and after such an event (Engstrom et al., 2010). The effects 
of cardiovascular disease on other major organs, such as the liver and lungs can therefore 
be far-reaching. Some degree of failure in the functioning of various organs such as the 
liver, lungs and intestines may be present (D’Adamo, 2005). In addition, an individual 
with the disease may experience constant fatigue, hypertension, and reduced mobility of 
the limbs (D’Adamo, 2005). Other effects of the disease may include ulceration and 
gangrene that may in extreme cases result in amputation (Feiring, 2005). As this disease 
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causes many bodily functions to be effected, it also has the potential to compromise the 
auditory system (Wiley, Torre, Cruickchanks, Nondhal, & Tweed, 2001).  
2.4 Cardiovascular Disease and the Auditory System 
The cochlea receives its blood supply from a tight network of arteries and normal 
blood supply is crucial for auditory transduction (Mom, Chazel, Gabrillargues, Gigila, & 
Avan, 2005). The cochlea is supplied by the labyrinthine artery. The labyrinthine artery 
arises from the meatal loop of the middle cerebral artery or a branch from the basilar 
artery, which penetrates into the internal acoustic meatus (Mom et al., 2005). Within the 
cochlea, both spiral and radial arteries are found. The modiolus artery has radial branches 
which enter the lateral wall of the cochlea, including the stria vascularis. The capillary 
network of the stria vascularis is extremely rich at the base of the cochlea compared to 
the apex and has a large capillary blood flow. 
A compromised cardiovascular system can impact on the integrity of the human 
auditory system (Cruickshanks, et al., 1998; Makishima, 1978). The sensitivity of the 
cochlea to decreased blood supply (ischemia/hypoxia) has been documented since 1961 
(Mom et al., 2005). Many animal studies have been conducted and all reported 
degenerative changes in inner and outer hair cells post hypoxia (Mom, Avan, Bonfils, & 
Gilian, 1999; Bachor, Selig, Jahnke, Rettinger, & Karmondy, 2001; Iwagaki, Suzuki, & 
Nakashima, 2000). It is postulated that cardiovascular disease may cause a disruption in 
the micro-vascular system of the stria vascularis in the cochlea. The decreased blood 
supply to the cochlea may result in cochlear degeneration (Torre et al., 2005). 
Degeneration in the stria vascularis affects the physical and chemical processes in the 
organ of Corti, thereby causing a possible hearing impairment (Schuknecht & Gacek, 
1993). 
The cochlea is tonotopically organized, as the base of the cochlea is responsible 
for identifying and transmitting low frequency stimuli and its apex of the cochlea is 
responsible for low frequency stimuli (Kros & Evans, 2006; Stach, 1998). This allows 
high sensitivity and frequency selectivity in the cochlea (Stach, 1998). The comparatively 
limited blood flow to the apex makes the apex of the cochlea vulnerable to degeneration 
which can present as a possible low frequency sensorineural hearing loss (Nakashima et 
al., 2003). 
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Hearing loss as a result of cochlear hypoxia was confirmed in study conducted by 
Dai, Jiang, and Gu (2000). These findings were supported by other studies which 
reported absent or reduced distortion product otoacoustic emissions following an 
ischemic injury to the cochlea (Schweinfurth, Cacace, & Parnes, 1997; Mom, Gilian, & 
Avan, 2008).  
2.5 Hearing Impairment 
Hearing impairment in adults is defined as a permanent unaided hearing threshold 
level of 41dB or greater in the better ear (World Health Organization, 2004). In 1995, the 
World Health Organisation estimated 120 million individuals to be living with a hearing 
impairment, 78 million of which were from third-world countries (Solarsh & Hofman, 
2006). Recent literature revealed that the number of individuals with a hearing 
impairment is likely to increase and that the age of onset is likely to decrease (De Sousa, 
De Castro Junior, Larsson, & Ching, 2009). The world report on disability (World Health 
Organization, 2011) reported 278 million people worldwide to have moderate to 
profound hearing impairments. In 2011, the global prevalence of hearing loss was 
estimated to be 9.8% in females and 12.2% in males, indicating that males have a higher 
prevalence rate than women (Stevens et al., 2011). 
The prevalence of hearing impairment in adults is significantly higher in middle- 
and low-income countries than in high-income countries (Stevens et al., 2011). In the 
Unites States of America, approximately 17% (38 million) of adults report some degree 
of hearing impairment (National Health Institute on Deafness and Other Communication 
Disorders, 2008). 
The Canadian Hearing Society (2002) reported a prevalence of hearing loss of 
20% in adults between 30-39 years of age and 24% in adults between 40-49 years of age. 
The prevalence of adults in Australia above the age of 26 years is reported to be 11.8% 
(Mathers, Smith, & Concha, 2000). In 1999, the European Hearing Instrument 
Manufacturers Association reported approximately 20% of adults in Europe to be having 
a hearing loss, 64% of which were below the age of 55 years. Shields (2006) reported the 
incidence of hearing loss to be as high as 25% (10.2 million) in Germany, approximately 
14% in Finland, 16% (7.2 million) in Italy, 10% in Denmark and Sweden and only 7% 
(7.6 million) in France. This indicates a range of prevalence rates amongst developed 
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countries. Obtaining accurate statistics on the prevalence of hearing loss in developing 
countries is difficult, because of limited research. In addition, records are scarce, since the 
majority of cases are not documented. This could be attributed to many individuals in 
developing countries not having access to medical professional services. 
The prevalence rate of hearing loss in Mexico, which is a developing country, 
ranges from 0.21% (profound hearing loss) to 29%. Latin America presented with higher 
prevalence rates when compared to Eastern countries such as India and China. Studies 
conducted in African countries reported lower prevalence rates compared to other 
developing countries. The prevalence rate appears to be higher in urban settings when 
compared to rural settings. Table 2 provides a summary of the data available on the 
prevalence of hearing loss in adults in developing countries. 
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Table 2 
Summary of the Prevalence of Hearing loss in Developing Countries 
Country 
/Region 
Authors Conclusion regarding Prevalence of Hearing Loss 
Tucci et al. (2009) 10% in rural areas and 6.8% in urban areas 
India 
 Mathers et al. (2000) 
9.8% in urban Lucknow and 7.3% in rural Lucknow in adults 
above the age of 26 years 
Tucci et al. (2009) 19% prevalence of hearing loss 
China 
Mathers et al. (2000) 4% in adults above the age of 26 years 
 
Madriz (2000) 
 
Studies reported an estimated prevalence of 21.07% 
(however, these statistics are skewed) 
Montes de Oca 
(1996) 
Study conducted on five indigenous groups revealed 
approximately 29.3% present with some degree of hearing 
loss. 
Madriz (2000) Estimated prevalence of 1.27% in 1995 
Latin America 
 
-Mexico 
 
 
 
 
-Columbia 
- Brazil 
Paiva et al. (2011) Estimated a prevalence of 11.2% in the elderly 
Prasansuk (2000) 
Study conducted in regions in Bangkok and Thailand revealed 
an overall prevalence of 13.6% of which 8.3% were 
sensorineural hearing losses 
Thailand 
Mathers et al. (2000) 11.6% in adults above the age of 41 years 
Sri Lanka Mathers et al. (2000) 21.7% in adults above the age of 26 years 
Pakistan Yucci et al. (2009) Prevalence of 18%. 
 
Mathers et al. (2000) 
 
4.5 % in adults above the age of 41 years 
Tucci et al. (2009) As high at 60% in certain settings 
Lasisi et at. (2010) 6.1% in the elderly (individuals above the age of 65 years) 
Solarsh & Hofman 
(2006) 
0.4% profound hearing loss. 
Solarsh & Hofman 
(2006) 
0.21% profound hearing loss 
 
Africa 
-Nigeria 
 
 
 
- Sierra Leone 
 
- Swaziland 
 
- South Africa  No statistics available on the adult population. 
Note. CVD=cardiovascular disease 
2.6 Cardiovascular Disease and Hearing Loss 
The debate of an association between cardiovascular disease and hearing loss 
began in the 1960s; however, limited research is available (Rosen & Olin, 1965; 
Rubenstein, Hildesheimer, Zohar, & Chillarovitz, 1977; Susmano & Rosenbush, 1988; 
Cocchiarella, Sharp, & Persky, 1995). An early study conducted by Rosen and Olin 
(1965) found that individuals with heart disease had poorer hearing sensitivity than 
individuals of similar age without heart disease had. Further research revealed a 
significant difference in pure-tone threshold audiometry between apparently healthy 
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subjects and those presenting with cardiovascular symptoms (Rubenstein et al, 1977; 
Susmano & Rosenbush, 1988). Susmano and Rosenbush (1988) took the debate further 
by reporting that the probability of individuals with cardiovascular disease presenting 
with a hearing loss were eight times higher than that for individuals without the disease. 
They also indicated that hearing loss appears to be an ‘early marker’ for individuals with 
the disease. 
Conversely, the results of a study by Miller and Ort (1965) revealed no 
association between hearing loss and risk factors for cardiovascular disease in the elderly 
population. Drettner et al. (1975) conducted a study in Sweden to investigate 
cardiovascular risk factors and hearing loss in 50-year-old men (n=1000). The hearing 
loss the participants presented with was attributed to noise exposure and/or conductive 
components. Furthermore, they suggested that further research was required to analyse 
the question concerning a possible relationship between cardiovascular diseases and 
hearing loss. 
The debate continued in the 1990s and researchers began to establish a firmer 
foothold regarding correlations and results. Gates et al. (1993) conducted a study 
(n=1662) investigating the relation of hearing in the elderly to the presence of 
cardiovascular disease and cardiovascular risk factors by comparing hearing status, the 
prevalence of the disease and the presence of associated risk factors. The results revealed 
that there was a small but significant association between hearing loss and cardiovascular 
disease. The study also revealed that a low frequency hearing loss was more prevalent 
than a high frequency hearing loss. The study further reported that gender may influence 
hearing loss in this population as more females were affected. This was the first study to 
describe audiological results of individuals with the disease. It did, however, not provide 
conclusive results and, furthermore, only targeted the geriatric population. 
A study conducted by Friedland, Cederberg and Tarima (2009) hypothesized that 
audiometric patterns can be associated with underlying cardiovascular disease. The 
results of their study (n=1168) indicated that there was a strong correlation between 
audiometric results and the disease. They furthermore established that patients presenting 
with a low frequency hearing loss should be regarded as being at risk for the disease and 
   31  
should be treated accordingly. The study concluded that more research was required to 
establish other audiometric trends. 
Once it had been ascertained that there is a relationship between cardiovascular 
disease and hearing loss and that the disease poses a risk factor for hearing loss, 
researchers began attempting to develop a better understanding of this relationship. They 
began investigating more specific pathologies (for instance, investigating the type of 
hearing loss and the variables which may influence hearing loss in individuals with the 
disease). Aimoni et al. (2010) assessed the role of cardiovascular disease in idiopathic, 
sudden onset sensorineural hearing loss and found that this disease does indeed play a 
significant role in patients with idiopathic, sudden onset sensorineural hearing loss.  
In a study conducted by Yamasoba, Kikuchi and Higo (2001), an association 
between vertebrobasilar insufficiency and cochlear hearing loss was confirmed. This was 
supported by Kim and Lee (2009) who found that individuals who suffer from 
vertebrobasilar ischemic stroke could also present with vertigo and hearing loss. 
It was also found that age and gender have a significant influence on hearing loss 
in individuals with cardiovascular disease (Pratt et al., 2009). In the study by Pratt et al. 
(2009), the prevalence rate of hearing loss in adults with the disease was reported to 
increase with age. Males were more likely to present with higher prevalence rates than 
women were. The results of this study are contradictory to that found by Gates et al. 
(1993), but both studies concluded that gender influences hearing loss in adults with 
cardiovascular disease. 
The studies referred to above serve to confirm that, despite limited research, there 
appears to be a strong link between the different types of cardiovascular disease and 
hearing loss. It is further postulated that gender and age may influence hearing loss in this 
population; however, more studies in this regard need to be conducted. 
2.7 The Audiologist as a Member of the Multi-Disciplinary Team 
The role of the audiologist in the diagnosis and management of hearing loss has 
been well established. Individuals living with hearing loss experience many physical, 
emotional and social challenges and may therefore present with an array of difficulties 
such as depression, dependence on others, withdrawal and situation avoidances 
(Weinstein, 2000). These difficulties, combined with the knowledge of a statistical 
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increase in the prevalence of hearing loss and the prevalence of cardiovascular disease 
have significant implications for the role of audiologists in the management of this 
disease. This highlights the need for early identification and also multidisciplinary 
assessment and intervention when dealing with hearing loss. 
Likewise, individuals living with cardiovascular disease contend with extreme 
mental stress, depression and anxiety (Kapoor & Singh, 1993). These individuals may 
experience some of the following: extreme fatigue, failure in the functioning of various 
organs, complications during pregnancy, and often physical limitations (Kapoor & Singh, 
1992). Management of individuals with this disease is, therefore, an intense process 
which requires the expertise of many medical professionals. 
2.8 Conclusion 
Cardiovascular disease has been identified as one of the most prevalent chronic 
diseases that are a major contributor to the global burden of disease. The disease not only 
affects the heart, but may also have an impact on the liver, lungs, and other parts of the 
body. It has been ascertained that reduced blood flow to the cochlea causes degeneration 
in the outer and inner hairs cells and impedes auditory function (Torre, et al., 2005; 
Schuknecht & Gacek, 1993). Despite this, there is a dearth of information on hearing loss 
in individuals diagnosed with cardiovascular disease. The majority of studies have been 
conducted in developed countries such as the United States of America, Australia and 
those in Europe. There are no known studies regarding cardiovascular disease and 
hearing loss conducted in South Africa. 
The majority of the available research did not utilize comprehensive audiological 
test batteries to describe the nature of the hearing loss. The current study will therefore 
utilize a comprehensive audiological test battery to provide a more holistic analysis 
regarding the nature of hearing loss in individuals with cardiovascular disease. Although 
some studies have established an association between this disease and hearing loss, they 
do not provide information regarding the prevalence of hearing loss associated with the 
disease. 
It is also evident that the sample in many of these studies comprised the geriatric 
population. As a result, the early age of onset of cardiovascular disease in developing 
countries has been neglected. For this reason the current study will focus on adults 
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between the ages of 40 years and 55 years, because they may present with different 
audiological characteristics. 
Although previous studies investigating cardiovascular disease and hearing loss 
have contributed valuable information, it has also raised many questions. These questions 
specifically relate to the nature of hearing loss in individuals diagnosed with 
cardiovascular disease and the prevalence of hearing loss in this population. This study 
therefore aims to determine what the prevalence of hearing loss is in individuals with the 
disease living in Gauteng. 
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CHAPTER 3 
 
METHODOLOGY 
 
This chapter discusses the aims of the study and the research design, procedure, 
instrumentation and data analysis procedures utilized to achieve those aims. This chapter 
also focuses on the three phases of the research process.  
3.1 Research Aims 
The primary aim of this study was to determine the prevalence of hearing loss in 
individuals diagnosed with cardiovascular disease. The null hypothesis being tested is 
that all adults with the disease present with normal hearing and the alternate hypothesis is 
that adults with the disease do present with some degree of hearing impairment. 
In order to achieve the primary aim, the sub-aims of the study were to (i) to 
describe audiological findings in these individuals, and (ii) to determine if age, gender, 
diagnosis and duration of cardiovascular disease influence hearing thresholds.  
3.2 Research design 
A research design is the structure or plan utilized to gather data to test a 
hypothesis (White, 2009). A quantitative, descriptive, survey research design was utilized 
for this study. 
In quantitative research, formalized tests and measuring instruments are applied to 
objectively specify the characteristics of data in numerical terms (Maxwell & Satake, 
2006). Data is analysed utilizing statistics and formulae (De Vaus, 2001). A quantitative 
approach was, therefore, appropriate for the purpose of this study since formalized 
audiological tests were administered, measuring instruments were utilized and data were 
analysed using statistics and numeric terms. 
Quantitative research is a broad term which encompasses many different types of 
research designs. One such design is a descriptive, survey research design. The main goal 
of descriptive research is to describe the characteristics of what is being studied (Mertens, 
2009). In descriptive studies, no attempt is made to change behaviour or conditions.  
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 Survey research designs allows for a description to be obtained from a specific 
group of individuals at a particular time (Gravetter & Forzano, 2009). Survey research 
designs enable clinical practitioners to obtained more information on certain 
characteristics of a group of patients/target group which ultimately leads to a better 
understanding of those individuals (Gravetter & Forzano, 2009; Houser & Bokovoy, 
2006). The variables or target group are examined only once and no therapy, intervention 
or change is implemented (Mertens, 2009; Thomas, 2003). A descriptive, survey research 
design was applicable to this study as the audiological characteristics of individuals 
diagnosed with cardiovascular disease were described utilizing frequencies, averages, and 
variability statistics. The target group was assessed only once and no intervention was 
provided. 
Each research design has its own strengths and weaknesses and a researcher 
chooses a design based on what is most suited to the research question. A quantitative, 
descriptive, survey research design allows for greater objectivity, accuracy and reliability 
of results, replicability and furthermore, it can be relatively cost and time efficient (Levin, 
2006; O’Neill, 2008; Tashakkori & Teddlie, 2003). It also decreases researcher bias, 
since subjects are unknown to the researcher and this enhances the generalization of 
results because it can include a greater number of subjects (O’Neill, 2008; Tashakkori & 
Teddlie, 2003). 
Although the advantages of this research design appear convincing, the 
disadvantages are equally numerous. A quantitative, descriptive, survey research research 
design does not allow for comparisons, because there is no control group and no 
manipulation of variables (that is, no intervention/therapy) thus limiting analysis 
regarding change (Shipman, 1997; Tashakkori & Teddlie, 2003). Results may further be 
limited in terms of analysis because they provide numerical descriptions rather than 
detailed narrative (Bland, 2001). The strengths and weaknesses of this design were taken 
into consideration when data analysis and implications of the study were discussed. 
3.3 Pilot Study 
A pilot study is a preliminary study which utilizes the data collection procedures 
and tools to reveal deficiencies in the proposed research (Lancaster, Dodd, & Williamson, 
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2004; Boynton, 2005). This allows for modifications to be made prior to commencement 
of the research (Rosnow & Rosenthal, 2006). 
3.3.1  Objectives 
The objective of the pilot study was to finalize data collection measurements, 
procedures and equipment needs. It also aimed to determine the ease of documentation of 
results and assess the ease of data coding (Table 4). 
3.3.2  Participants 
The pilot study was conducted on four individuals who met the same selection 
criteria as for the main study. Three participants were male and one female. Their average 
age was 48 years and five months (range: 43 – 51 years; standard deviation: 3.7) Three of 
the participants were diagnosed with coronary artery disease and one participant (a male) 
with cardiomyopathy. One participant reported experiencing hearing difficulties in noisy 
environments. The other three participants reported no hearing difficulties. 
3.3.3  Procedures 
The steps outlined in the main study were followed and all measuring instruments 
were completed and coded. Participants were recruited from the Out Patient Department 
at South Rand Hospital. Once it was ascertained that the individuals met the selection 
criteria informed consent was obtained (Appendix B). Participants could ask questions 
and make comments at any point whilst completing the questionnaire and also during the 
testing process. Table 4 indicates the changes which have been made to the questionnaire 
based on feedback received from the participants. 
3.3.4  Results and recommendations 
The objectives, materials and equipment, procedures, results and 
recommendations made after the completion of the pilot study are outlined in Table 4. 
 
 
 
3
7
  
T
a
b
le
 4
: 
M
o
d
if
ic
a
ti
o
n
s/
C
o
n
si
d
er
a
ti
o
n
s 
d
u
ri
n
g
 t
h
e 
P
il
o
t 
S
tu
d
y 
O
b
je
ct
iv
e 
M
ea
su
re
s 
a
n
d
 
E
q
u
ip
m
e
n
t 
R
es
u
lt
s 
R
ec
o
m
m
en
d
a
ti
o
n
s 
1
. 
T
o
 e
v
al
u
at
e 
th
e 
co
m
p
re
h
en
si
v
en
es
s 
an
d
 
th
e 
cl
ar
it
y
 o
f 
th
e 
q
u
es
ti
o
n
n
ai
re
 
Q
u
es
ti
o
n
n
ai
re
 
(A
p
p
en
d
ix
 A
) 
T
h
re
e 
q
u
es
ti
o
n
s 
ca
u
se
d
 c
o
n
fu
si
o
n
 a
m
o
n
g
 s
o
m
e 
p
ar
ti
ci
p
an
ts
 w
h
o
 r
eq
u
ir
ed
 f
u
rt
h
er
 e
x
am
p
le
s 
an
d
 
cl
ar
if
ic
at
io
n
 i
n
 o
rd
er
 t
o
 a
ss
is
t 
th
em
 i
n
 a
n
sw
er
in
g
 
ac
cu
ra
te
ly
. 
 
T
h
e 
ch
an
g
es
 t
o
 t
h
e 
th
re
e 
q
u
es
ti
o
n
s 
w
er
e 
m
ad
e 
as
 
re
co
m
m
en
d
ed
 b
y
 t
h
e 
p
ar
ti
ci
p
an
ts
. 
 
2
. 
T
o
 d
et
er
m
in
e 
th
e 
co
m
p
re
h
en
si
v
en
es
s 
o
f 
th
e 
in
st
ru
ct
io
n
s/
te
rm
in
o
lo
g
y
 
N
o
n
e 
T
h
e 
in
st
ru
ct
io
n
s 
p
ro
v
id
ed
 f
o
r 
al
l 
te
st
 p
ro
ce
d
u
re
s 
w
er
e 
cl
ea
r,
 c
o
n
ci
se
 a
n
d
 n
o
 a
m
b
ig
u
it
y
 w
as
 r
ep
o
rt
ed
. 
 
O
n
e 
p
ar
ti
ci
p
an
t 
re
p
o
rt
ed
 b
ei
n
g
 u
n
su
re
 a
b
o
u
t 
w
h
en
 
to
 r
es
p
o
n
d
 d
u
ri
n
g
 b
o
n
e 
co
n
d
u
c
ti
o
n
 m
as
k
in
g
; 
h
o
w
ev
er
, 
af
te
r 
a 
re
p
ea
t 
in
st
ru
ct
io
n
 s
h
e 
w
as
 a
b
le
 t
o
 
re
sp
o
n
d
 a
p
p
ro
p
ri
at
el
y
. 
 
N
o
 c
h
an
g
es
 w
er
e 
re
q
u
ir
ed
. 
 T
h
e 
re
se
ar
ch
er
 n
ee
d
s 
to
 e
n
su
re
 t
h
at
 i
n
st
ru
ct
io
n
s 
re
g
ar
d
in
g
 t
h
e 
re
sp
o
n
se
 o
f 
th
e 
p
ar
ti
ci
p
an
ts
 d
u
ri
n
g
 
b
o
n
e 
co
n
d
u
ct
io
n
 m
as
k
in
g
 a
re
 c
le
ar
. 
3
. 
T
o
 a
ss
es
s 
th
e 
su
it
a
b
il
it
y
 
an
d
 e
as
e 
o
f 
u
se
 o
f 
eq
u
ip
m
en
t 
•
 
O
to
sc
o
p
e 
•
 
T
y
m
p
an
o
m
et
er
 
•
 
A
u
d
io
m
et
er
 
•
 
O
A
E
 m
ac
h
in
e 
T
h
e 
eq
u
ip
m
en
t 
u
ti
li
ze
d
 d
u
ri
n
g
 t
es
ti
n
g
 w
as
 o
p
er
at
ed
 
w
it
h
 e
as
e 
an
d
 n
o
 t
ec
h
n
ic
al
 d
if
fi
cu
lt
ie
s 
w
er
e 
en
co
u
n
te
re
d
. 
T
h
e 
re
su
lt
s 
p
ro
v
id
ed
 v
al
u
ab
le
 
in
fo
rm
at
io
n
 w
h
ic
h
 c
o
n
tr
ib
u
te
d
 t
o
 t
h
e 
b
as
ic
 t
es
t 
b
at
te
ry
 o
f 
an
 a
u
d
io
lo
g
ic
al
 e
v
al
u
at
io
n
. 
 
N
o
 c
h
an
g
es
 w
er
e 
re
q
u
ir
ed
. 
4
. 
T
o
 d
et
er
m
in
e 
th
e 
le
n
g
th
 o
f 
ti
m
e 
ta
k
en
 t
o
 
co
m
p
le
te
 t
h
e 
ev
al
u
at
io
n
 
S
to
p
w
at
ch
 
T
h
e 
d
at
a 
co
ll
ec
ti
o
n
 p
ro
ce
d
u
re
 t
o
o
k
 a
p
p
ro
x
im
at
el
y
 
4
5
 m
in
u
te
s 
fo
r 
ea
ch
 p
ar
ti
ci
p
an
t 
(i
n
cl
u
d
in
g
 
co
m
p
le
ti
o
n
 o
f 
th
e 
q
u
es
ti
o
n
n
ai
re
 a
n
d
 f
ee
d
b
ac
k
 o
f 
re
su
lt
s)
. 
 
 
P
ar
ti
ci
p
an
ts
 n
ee
d
 t
o
 b
e 
in
fo
rm
ed
 t
h
at
 t
h
e 
ap
p
o
in
tm
en
t 
w
il
l 
b
e 
sc
h
ed
u
le
d
 f
o
r 
ap
p
ro
x
im
at
el
y
 
4
5
 m
in
u
te
s.
 
5
. 
T
o
 a
ss
es
s 
th
e 
ea
se
 o
f 
re
co
rd
in
g
 r
es
u
lt
s 
D
at
a 
co
ll
ec
ti
o
n
 f
o
rm
s,
 
fo
r 
ex
am
p
le
 
au
d
io
g
ra
m
, 
fo
rm
 
u
ti
li
ze
d
 t
o
 r
ec
o
rd
 O
A
E
 
re
su
lt
s 
(A
p
p
en
d
ix
 C
) 
 
A
ll
 r
es
u
lt
s 
w
er
e 
re
co
rd
ed
 o
n
 t
h
e 
d
at
a 
co
ll
ec
ti
o
n
 
fo
rm
. 
T
h
e 
re
su
lt
s 
w
er
e 
th
en
 p
ri
n
te
d
 a
n
d
 a
tt
ac
h
ed
 t
o
 
th
e 
au
d
io
lo
g
ic
al
 e
v
al
u
at
io
n
 f
o
rm
. 
N
o
 c
h
an
g
es
 w
er
e 
re
co
m
m
en
d
ed
. 
6
. 
T
o
 d
et
er
m
in
e 
th
e 
ea
se
 
o
f 
co
d
in
g
 o
f 
re
su
lt
s 
E
x
ce
l 
sp
re
ad
sh
ee
t.
 
D
at
a 
w
as
 c
o
d
ed
 a
cc
o
rd
in
g
 t
o
 t
h
e 
d
at
a 
d
ef
in
it
io
n
s 
A
 
st
at
is
ti
ci
an
 w
as
 c
o
n
su
lt
ed
 o
n
 t
h
e 
ac
cu
ra
c
y
 o
f 
th
e 
N
o
 c
h
an
g
es
 w
er
e 
re
co
m
m
en
d
ed
. 
 
 
 
3
8
  
O
b
je
ct
iv
e 
M
ea
su
re
s 
a
n
d
 
E
q
u
ip
m
e
n
t 
R
es
u
lt
s 
R
ec
o
m
m
en
d
a
ti
o
n
s 
co
d
in
g
 o
n
 m
ea
su
ri
n
g
 i
n
st
ru
m
en
ts
. 
A
lt
h
o
u
g
h
 c
o
d
in
g
 
o
f 
d
at
a 
w
as
 t
im
e 
co
n
su
m
in
g
, 
th
e 
co
d
ed
 d
at
a 
al
lo
w
s 
fo
r 
q
u
ic
k
er
 a
n
d
 e
as
ie
r 
an
al
y
si
s 
o
f 
d
at
a 
(f
o
r 
p
ar
am
et
ri
c
 m
ea
su
re
s 
an
d
 f
o
r 
d
es
cr
ip
ti
v
e 
st
at
is
ti
cs
).
 
 
N
o
te
. 
O
A
E
=
o
to
ac
o
u
st
ic
 e
m
is
si
o
n
s 
3.3.5  Summary 
Overall, the pilot study determined the feasibility of the test procedures and 
equipment utilized in this study. It has also highlighted the changes which were required 
to ensure that the questionnaire and participant instruction was more comprehensive. 
These modifications were made for data collection during the main study  
3.4 Main Study 
3.4.1  Participant selection 
3.4.1.1   Sampling strategy  
A non-probability, purposive sampling strategy was utilized for this study. A non-
probability sampling strategy is one in which the researcher creates a framework to obtain 
a sample specific to the selected research design (Baker, 1994). This allows the 
researcher to select participants who meet specific selection criteria (Burns & Grove, 
2001). Purposive sampling is often used in studies of relatively infrequent phenomena 
such as rare diseases or disorders (Maxwell & Satake, 2006). Advantages of this method 
of sampling is that “a sample of subjects can be created that appears to have the major 
characteristics that an investigator wishes to study” as well as to “replicate the proportion 
of such characteristics found in a targeted population” (Maxwell & Satake, 2006, p. 97). 
Non-probability sampling may have a weak basis for generalization of results and is 
prone to biases which can result in an unrepresentative sample being obtained (Fife-
Schaw, 2000; Walliman, 2001). 
3.4.1.2   Participant selection criteria 
The participant selection criteria, the rationale for inclusion and information 
regarding implementation are presented in Table 5. 
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3.4.2  Participant description 
The sample comprised a total of 92 participants (N = 92), 60 males and 32 
females. The age of participants ranged from 40 years to 54 years and 9 months with an 
average age of 48 years and five months (standard deviation: 3.70). The duration of 
cardiovascular disease (from date of diagnosis to date of testing) ranged from 7 months to 
4 years and one month with an average of two years and two months (standard deviation: 
0.95). 
 Table 6 provides a summary of the participants in relation to gender and 
diagnosis.  
 
Table 6 
 
Summary of Participant Description in Relation to Gender and Diagnosis 
 
 Variable 
 Gender Diagnosis 
 Males Females CAD CM 
Number of 
participants 
60 32 58 34 
Note. CAD=Coronary Artery Disease; CM=cardiomyopathy 
 
All participants reported the following intervention after being diagnosed with 
coronary artery disease or cardiomyopathy: diet modification, lifestyle modifications, and 
medication and follow-up appointments. Forty three percent of participants were 
hospitalized due to uncontrolled hypertension and received the aforementioned 
intervention thereafter. Fourteen percent of participants underwent surgery due to cardiac 
complications. 
Eight participants were unable to read and/or write. The information was provided 
verbally and these participants responded verbally to the questions in the questionnaire. 
The remainder of the participants demonstrated adequate English proficiency as they 
were able to respond appropriately to Yes/No-questions and provide information 
regarding their health and hearing status in English. Those participants were therefore 
able to complete the case history questionnaire. All participants included in the study 
were able to follow simple instructions provided in English and were able to repeat 
English spondee words. 
  
43
 
3.4.3  Equipment and measures 
 The following equipment was utilized during the data collection procedure: 
• Sound treated booth 
• Heine Mini 2000 otoscope and specula 
• A recently calibrated GSI 38 tympanometer with built-in acoustic reflex testing 
settings 
• Probe tips 
• A recently calibrated GSI 61 clinical audiometer 
• Subject hand-response button 
• Test headset (matched set TDH-50P) 
• Bone vibrator (B71) 
• Test microphone/monitor headset with coiled cord 
• Talkback microphone 
• Spondee Wordlist (Punch & Howard, 1985) 
• National Acoustic Laborotories-Arthur Boothroyd (NAL-AB) wordlist 
(American Speech-Language and Hearing Association, 1988). The use of these 
wordlists at supra-threshold levels provides valid and reliable speech 
discrimination results in speakers of South African English (Wilson, Jones, & 
Fridjhon, 1998) 
• An AudX Oto-Acoustic Machine 
 
In order to meet the requirements posed by the research aims, an audiological test 
battery was utilized. The use of the test battery approach allows for assessment of all 
components of the auditory pathway and it enables the cross-check principle to be applied 
(American Speech-Language and Hearing Association, 2004). The cross-check principle 
compares independent measures of the test battery to determine if results are consistent 
and reliable (Jerger & Hayes, 1976; Turner, 2003). The following tests comprised the test 
battery: otoscopic examination, immittance testing, pure-tone audiometry, speech 
audiometry and otoacoustic emissions. This test battery was selected because it enabled 
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an assessment of the integrity of the auditory pathway, allowed for the cross-check 
principle to be applied and allowed for determining a possible site of lesion. Table 7 
provides information regarding the procedures implemented for the audiological 
evaluation and the rationale for each procedure. 
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h
re
sh
o
ld
s 
fo
r 
5
0
0
, 
1
0
0
0
 a
n
d
 2
0
0
0
 
  
4
7
 
A
u
d
io
lo
g
ic
a
l 
P
ro
ce
d
u
re
 
A
im
s 
a
n
d
 R
a
ti
o
n
a
le
 
Im
p
le
m
en
ta
ti
o
n
 
 P
u
re
 t
o
n
e 
au
d
io
m
et
ry
 c
o
n
si
st
s 
o
f 
tw
o
 
p
ro
ce
d
u
re
s:
 a
ir
 c
o
n
d
u
ct
io
n
 t
es
ti
n
g
 a
n
d
 b
o
n
e 
co
n
d
u
ct
io
n
 t
es
ti
n
g
. 
A
ir
 c
o
n
d
u
ct
io
n
 t
es
ti
n
g
 
u
ti
li
ze
s 
a 
h
ea
d
se
t 
an
d
 a
ss
es
se
s 
th
e 
en
ti
re
 
p
er
ip
h
er
al
 a
u
d
it
o
ry
 (
H
u
g
h
es
 &
 P
en
sa
k
, 
2
0
0
7
).
 
B
o
n
e 
co
n
d
u
ct
io
n
 t
es
ti
n
g
 u
ti
li
ze
s 
a 
b
o
n
e 
v
ib
ra
to
r 
an
d
 b
y
p
as
se
s 
th
e 
co
n
d
u
ct
iv
e 
co
m
p
o
n
en
t 
o
f 
th
e 
ea
r 
to
 s
ti
m
u
la
te
 t
h
e 
co
ch
le
a,
 
th
u
s 
p
ro
v
id
in
g
 s
en
so
ri
n
eu
ra
l 
re
su
lt
s 
(H
u
g
es
 &
 
P
en
sa
k
, 
2
0
0
7
).
 
  
H
z.
 T
ab
le
 9
 p
ro
v
id
es
 t
h
e 
W
o
rl
d
 H
ea
lt
h
 O
rg
an
iz
at
io
n
’s
 g
ra
d
es
 o
f 
h
ea
ri
n
g
 i
m
p
ai
rm
en
t.
 
 T
h
e 
n
at
u
re
 o
f 
h
ea
ri
n
g
 l
o
ss
 w
as
 c
la
ss
if
ie
d
 a
s:
 
1
. 
C
o
n
d
u
ct
iv
e:
 a
ir
 c
o
n
d
u
ct
io
n
 t
h
re
sh
o
ld
s 
w
er
e 
re
d
u
ce
d
, 
b
u
t 
b
o
n
e 
co
n
d
u
ct
io
n
 
th
re
sh
o
ld
s 
w
er
e 
w
it
h
in
 n
o
rm
al
 l
im
it
s 
2
. 
S
en
so
ri
n
eu
ra
l:
 A
 h
ea
ri
n
g
 l
o
ss
 i
s 
se
n
so
ri
n
eu
ra
l 
in
 n
at
u
re
 w
h
en
 b
o
th
 a
ir
- 
an
d
 b
o
n
e-
co
n
d
u
ct
io
n
 t
h
re
sh
o
ld
s 
ar
e 
el
ev
at
ed
 b
u
t 
w
it
h
in
 1
0
d
B
 o
f 
ea
ch
 o
th
er
 (
R
o
es
er
 
V
a
le
n
te
, 
&
 H
o
sf
o
rd
-D
u
n
n
, 
2
0
0
7
).
 P
ar
ti
ci
p
an
ts
 w
h
o
 p
re
se
n
te
d
 w
it
h
 e
le
v
at
ed
 a
ir
 
an
d
 b
o
n
e 
co
n
d
u
ct
io
n
 t
h
re
sh
o
ld
s 
b
u
t 
w
it
h
 a
n
 a
ir
-b
o
n
e 
g
ap
 o
f 
le
ss
 t
h
an
 1
0
d
B
 w
er
e 
cl
as
si
fi
ed
 a
s 
p
re
se
n
ti
n
g
 w
it
h
 a
 s
en
so
ri
n
eu
ra
l 
h
ea
ri
n
g
 l
o
ss
 
3
. 
M
ix
ed
: 
B
o
th
 a
ir
 c
o
n
d
u
ct
io
n
 a
n
d
 b
o
n
e 
co
n
d
u
ct
io
n
 t
h
re
sh
o
ld
s 
w
er
e 
re
d
u
ce
d
 a
n
d
 
n
o
t 
w
it
h
in
 n
o
rm
al
 l
im
it
s.
 
 
S
p
ee
ch
 a
u
d
io
m
et
ry
 
S
p
ee
ch
 a
u
d
io
m
et
ry
 c
o
n
si
st
s 
o
f 
tw
o
 
co
m
p
o
n
en
ts
: 
sp
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 a
n
d
 
sp
ee
ch
 d
is
cr
im
in
at
io
n
. 
 T
h
e 
sp
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 d
et
er
m
in
es
 t
h
e 
so
ft
es
t 
le
v
el
 a
t 
w
h
ic
h
 a
n
 i
n
d
iv
id
u
al
 c
an
 h
ea
r 
sp
ee
ch
/f
am
il
ia
r 
w
o
rd
s 
(G
el
fa
n
d
, 
2
0
0
9
).
 
 S
p
ee
ch
 d
is
cr
im
in
at
io
n
 t
es
ti
n
g
 i
s 
a 
su
p
ra
-
th
re
sh
o
ld
 t
es
t 
w
h
ic
h
 d
et
er
m
in
es
 h
o
w
 w
el
l 
an
 
in
d
iv
id
u
al
 r
es
p
o
n
d
s 
to
 d
if
fe
re
n
t 
le
v
el
s 
o
f 
lo
u
d
n
es
s.
 (
K
in
g
 e
t 
al
, 
1
9
9
2
).
 I
t 
th
er
ef
o
re
 
su
p
p
li
es
 i
n
fo
rm
at
io
n
 r
eg
ar
d
in
g
 t
h
e 
ty
p
e 
o
f 
se
n
so
ri
n
eu
ra
l 
h
ea
ri
n
g
 l
o
ss
 (
fo
r 
ex
am
p
le
 
co
ch
le
ar
 v
er
su
s 
re
tr
o
co
ch
le
ar
) 
(G
el
fa
n
d
, 
2
0
0
9
).
 T
h
is
 d
ia
g
n
o
st
ic
 i
n
fo
rm
a
ti
o
n
 p
ro
v
id
es
 
in
si
g
h
t 
re
g
ar
d
in
g
 t
h
e 
p
o
ss
ib
le
 s
it
e 
o
f 
le
si
o
n
 
(G
el
fa
n
d
, 
2
0
0
9
).
 
 W
h
en
 c
o
n
d
u
ct
in
g
 s
p
ee
ch
 a
u
d
io
m
et
ry
, 
th
e 
d
if
fe
re
n
ce
 b
et
w
ee
n
 t
h
e 
sp
ee
ch
 r
ec
ep
ti
o
n
 
th
re
sh
o
ld
 a
n
d
 t
h
e 
p
u
re
 t
o
n
e 
av
er
ag
e 
(o
f 
ea
ch
 
T
o
 o
b
ta
in
 a
 s
p
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
, 
p
ar
ti
ci
p
an
ts
 w
er
e 
in
st
ru
ct
ed
 t
o
 r
ep
ea
t 
sp
o
n
d
ee
 
w
o
rd
s.
 T
h
e 
in
te
n
si
ty
 l
ev
el
 w
as
 d
ec
re
as
ed
 i
n
 1
0
d
B
 s
te
p
s 
u
n
ti
l 
th
e 
p
ar
ti
ci
p
an
t 
w
as
 
u
n
ab
le
 t
o
 r
es
p
o
n
d
 c
o
rr
ec
tl
y
 a
ft
er
 w
h
ic
h
 t
h
e 
in
te
n
si
ty
 w
as
 i
n
cr
ea
se
d
 i
n
 5
d
B
 i
n
cr
em
en
ts
 
an
d
 f
o
u
r 
w
o
rd
s 
w
er
e 
p
re
se
n
te
d
 a
t 
ea
ch
 l
ev
el
. 
T
h
e 
sp
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 w
as
 
d
o
cu
m
en
te
d
 a
s 
th
e 
lo
w
es
t 
le
v
el
 a
t 
w
h
ic
h
 t
h
e 
p
ar
ti
ci
p
an
t 
p
ro
d
u
ce
d
 a
 c
o
rr
ec
t 
re
sp
o
n
se
 
m
o
re
 t
h
an
 5
0
%
 o
f 
th
e 
ti
m
e.
 T
w
o
 c
o
rr
ec
t 
re
sp
o
n
se
s 
o
u
t 
o
f 
fo
u
r 
p
re
se
n
ta
ti
o
n
s 
w
er
e 
d
o
cu
m
en
te
d
 a
s 
a 
th
re
sh
o
ld
. 
 F
o
r 
th
e 
u
n
co
m
fo
rt
ab
le
 l
o
u
d
n
es
s 
le
v
el
, 
th
e 
in
te
n
si
ty
 w
as
 i
n
cr
ea
se
d
 i
n
 5
d
B
 i
n
cr
em
en
ts
 
an
d
 t
h
e 
p
ar
ti
ci
p
an
ts
 r
es
p
o
n
d
ed
 b
y
 s
a
y
in
g
 ‘
st
o
p
’ 
w
h
en
 t
h
e 
so
u
n
d
 w
as
 f
el
t 
to
 b
e 
to
o
 
lo
u
d
. 
In
d
iv
id
u
al
s 
w
it
h
 n
o
rm
al
 h
ea
ri
n
g
 s
h
o
u
ld
 p
re
se
n
t 
w
it
h
 a
n
 u
n
co
m
fo
rt
ab
le
 l
o
u
d
n
es
s 
le
v
el
 o
f 
b
et
w
ee
n
 8
0
d
B
 a
n
d
 1
0
0
d
B
 (
K
ap
la
n
, 
G
la
d
st
o
n
e 
&
 L
lo
y
d
, 
1
9
9
3
).
  
 P
ar
ti
ci
p
an
ts
 w
er
e 
al
so
 r
eq
u
ir
ed
 t
o
 r
ep
ea
t 
li
st
s 
o
f 
w
o
rd
s 
at
 d
if
fe
re
n
t 
lo
u
d
n
es
s 
le
v
el
s 
fo
r 
sp
ee
ch
 d
is
cr
im
in
at
io
n
 t
es
ti
n
g
. 
N
A
L
-A
B
 w
o
rd
 l
is
ts
 w
er
e 
u
ti
li
ze
d
 f
o
r 
sp
ee
ch
 
d
is
cr
im
in
at
io
n
 t
es
ti
n
g
 a
n
d
 N
A
L
 s
co
ri
n
g
 p
ro
ce
d
u
re
s 
w
er
e 
u
ti
li
ze
d
 a
s 
d
es
cr
ib
ed
 b
y
 
D
ea
n
 &
 M
cD
er
m
o
tt
 (
2
0
0
0
) 
 T
h
e 
d
y
n
am
ic
 r
an
g
e 
is
 t
h
e 
d
if
fe
re
n
ce
 (
in
 d
B
) 
b
et
w
ee
n
 t
h
e 
u
n
co
m
fo
rt
ab
le
 l
o
u
d
n
es
s 
le
v
el
 a
n
d
 t
h
e 
sp
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 (
G
el
fa
n
d
, 
2
0
0
9
).
 T
h
e 
d
y
n
am
ic
 r
an
g
e,
 i
n
 
es
se
n
ce
, 
is
 a
n
 i
n
d
iv
id
u
al
s’
 u
sa
b
le
 l
is
te
n
in
g
 r
an
g
e.
 T
h
e 
d
y
n
a
m
ic
 r
an
g
e 
o
f 
ea
ch
 
p
ar
ti
ci
p
an
t 
w
as
 c
al
cu
la
te
d
 u
ti
li
zi
n
g
 t
h
e 
fo
ll
o
w
in
g
 f
o
rm
u
la
: 
  
4
8
 
A
u
d
io
lo
g
ic
a
l 
P
ro
ce
d
u
re
 
A
im
s 
a
n
d
 R
a
ti
o
n
a
le
 
Im
p
le
m
en
ta
ti
o
n
 
ea
r)
 i
s 
ca
lc
u
la
te
d
. 
A
s 
b
o
th
 t
h
e 
sp
ee
ch
 
re
ce
p
ti
o
n
 t
h
re
sh
o
ld
 a
n
d
 t
h
e 
p
u
re
 t
o
n
e 
av
er
ag
e 
ar
e 
re
p
re
se
n
ta
ti
v
e 
o
f 
th
re
sh
o
ld
s,
 t
h
e
y
 s
h
o
u
ld
 
n
o
t 
b
e
 s
ig
n
if
ic
an
tl
y
 d
if
fe
re
n
t 
(H
ig
h
es
 &
 
P
en
sa
k
, 
2
0
0
7
).
 
 
U
n
co
m
fo
rt
ab
le
 l
o
u
d
n
es
s 
le
v
el
 -
 s
p
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 =
 d
y
n
am
ic
 r
a
n
g
e 
(d
B
) 
(K
ap
la
n
 e
t 
al
.,
 1
9
9
3
).
 
 T
h
e 
co
rr
el
at
io
n
 b
et
w
e
en
 s
p
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 a
n
d
 p
u
re
 t
o
n
e 
av
er
ag
e 
w
as
 a
ls
o
 
ca
lc
u
la
te
d
 f
o
r 
ea
ch
 p
ar
ti
ci
p
an
t 
fo
r 
b
o
th
 t
h
e 
ri
g
h
t 
ea
r 
an
d
 t
h
e 
le
ft
 e
ar
. 
T
h
e 
d
if
fe
re
n
ce
 (
in
 
d
B
) 
b
et
w
ee
n
 t
h
e 
sp
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
 a
n
d
 t
h
e 
p
u
re
 t
o
n
e 
av
er
ag
e 
o
f 
th
e 
sa
m
e 
ea
r 
is
 t
h
e 
sp
ee
ch
 r
ec
ep
ti
o
n
 t
h
re
sh
o
ld
-p
u
re
 t
o
n
e 
av
er
ag
e 
co
rr
el
at
io
n
 (
B
lu
es
to
n
e,
 2
0
0
3
).
 A
 
co
rr
el
at
io
n
 o
f 
8
d
B
 o
r 
le
ss
 i
s 
co
n
si
d
er
ed
 t
o
 b
e 
a 
g
o
o
d
 c
o
rr
el
at
io
n
 a
n
d
 i
s 
in
d
ic
at
iv
e 
o
f 
re
li
ab
le
 r
es
u
lt
s 
(B
lu
es
to
n
e,
 2
0
0
3
; 
H
er
g
en
re
d
er
 &
 T
an
g
, 
1
9
9
2
).
 
 
D
is
to
rt
io
n
 p
ro
d
u
ct
 
o
to
ac
o
u
st
ic
 e
m
is
si
o
n
s 
 
 
O
to
ac
o
u
st
ic
 e
m
is
si
o
n
s 
(O
A
E
s)
 a
re
 a
n
 
o
b
je
ct
iv
e 
m
ea
su
re
 t
h
at
 r
ec
o
rd
s 
th
e 
el
ec
tr
o
p
h
y
si
o
lo
g
ic
al
 r
es
p
o
n
se
s 
o
f 
th
e 
o
u
te
r 
h
ai
r 
ce
ll
 f
u
n
ct
io
n
 i
n
 t
h
e 
co
ch
le
a 
(T
o
rr
e 
et
 a
l.
, 
2
0
0
5
).
 O
A
E
s 
ca
n
 b
e 
u
se
d
 t
o
 d
et
ec
t 
co
ch
le
ar
 
d
y
sf
u
n
ct
io
n
 b
ef
o
re
 i
t 
is
 e
v
id
en
t 
fr
o
m
 p
u
re
-t
o
n
e 
au
d
io
m
et
ry
. 
O
A
E
s 
al
so
 p
ro
v
id
e 
fr
eq
u
en
c
y
-
sp
ec
if
ic
 a
u
d
io
lo
g
ic
al
 i
n
fo
rm
at
io
n
 (
H
al
l,
 2
0
0
0
).
 
O
A
E
s,
 a
n
d
 t
h
er
ef
o
re
, 
p
la
y
 a
n
 i
n
te
g
ra
l 
ro
le
 i
n
 
th
e 
ea
rl
y
 i
d
en
ti
fi
ca
ti
o
n
 a
n
d
 d
ia
g
n
o
si
s 
o
f 
h
ea
ri
n
g
 l
o
ss
 (
L
is
o
w
sk
a 
G
rz
eg
o
rs
, 
M
o
ra
w
sk
i,
 
&
 S
tr
o
je
k
, 
2
0
0
1
).
 
 W
h
en
 c
o
n
d
u
ct
in
g
 O
A
E
s,
 i
t 
is
 i
m
p
o
rt
an
t 
to
 
co
n
si
d
er
 t
h
e 
si
g
n
al
-t
o
-n
o
is
e 
ra
ti
o
. 
T
h
is
 r
at
io
 i
s 
th
e 
d
if
fe
re
n
ce
 (
in
 d
B
) 
b
et
w
ee
n
 t
h
e 
le
v
el
 o
f 
th
e 
re
sp
o
n
se
 (
in
 d
B
) 
an
d
 t
h
e 
le
v
el
 o
f 
b
ac
k
g
ro
u
n
d
 
n
o
is
e 
(i
n
 d
B
) 
(R
o
b
in
et
te
 &
 G
la
tt
k
e,
 2
0
0
2
).
 
T
h
e 
si
g
n
al
-t
o
-n
o
is
e 
ra
ti
o
 i
s 
u
ti
li
ze
d
 a
s 
a 
m
ea
su
re
 o
f 
re
li
ab
il
it
y
 a
s 
it
 p
ro
v
id
es
 
in
fo
rm
at
io
n
 r
eg
ar
d
in
g
 t
h
e 
co
n
tr
ib
u
ti
o
n
 o
f 
n
o
is
e.
  
 
T
h
e 
te
st
 w
as
 c
o
n
d
u
ct
ed
 i
n
 a
 s
o
u
n
d
 t
re
at
ed
 b
o
o
th
 t
o
 e
n
su
re
 r
el
ia
b
le
 r
es
u
lt
s.
 P
ar
ti
ci
p
an
ts
 
w
er
e 
in
st
ru
ct
ed
 t
o
 r
em
ai
n
 s
il
en
t 
an
d
 s
ti
ll
 f
o
r 
th
e 
d
u
ra
ti
o
n
 o
f 
th
is
 t
es
t.
 O
n
ce
 t
h
e 
te
st
 w
as
 
co
m
p
le
te
d
 t
h
e 
re
su
lt
s 
w
er
e 
d
o
c
u
m
en
te
d
 o
n
 a
 r
ec
o
rd
 s
h
ee
t 
(A
p
p
en
d
ix
 C
).
 
D
is
to
rt
io
n
 p
ro
d
u
ct
 o
to
ac
o
u
st
ic
 e
m
is
si
o
n
s 
w
er
e 
as
se
ss
ed
 a
t 
th
e 
fo
ll
o
w
in
g
 f
re
q
u
en
ci
es
: 
7
5
0
H
z,
 1
0
0
0
H
z,
 2
0
0
0
H
z,
 3
0
0
0
H
z,
 4
0
0
0
H
z,
 6
0
0
0
H
z 
an
d
 8
0
0
0
H
z.
 T
h
e 
st
re
n
g
th
 o
f 
th
e 
O
A
E
 (
in
 d
B
) 
w
as
 r
ec
o
rd
ed
 a
lo
n
g
 w
it
h
 t
h
e 
p
as
s/
re
fe
r 
re
su
lt
. 
T
h
e 
p
as
s/
fa
il
 c
ri
te
ri
a 
u
ti
li
ze
d
 w
as
 t
h
at
 o
f 
th
e 
A
u
d
X
 A
d
u
lt
 S
ta
n
d
ar
d
 S
cr
ee
n
in
g
 P
ro
to
co
l 
w
h
ic
h
 w
as
 b
as
ed
 o
n
 
th
e 
in
d
iv
id
u
al
 p
ro
to
co
l 
o
f 
th
e 
in
st
ru
m
en
ta
ti
o
n
, 
si
g
n
al
-t
o
-n
o
is
e 
ra
ti
o
, 
th
e 
st
re
n
g
th
 o
f 
th
e 
O
A
E
 a
n
d
 a
cc
ep
ta
b
le
 f
al
se
-p
o
si
ti
v
e 
an
d
 f
al
se
-n
eg
at
iv
e 
ra
te
s.
  
A
 r
es
u
lt
 o
f 
an
 O
A
E
 i
s 
co
n
si
d
er
ed
 t
o
 b
e 
re
li
ab
le
 i
f 
th
e 
si
g
n
al
-t
o
-n
o
is
e 
ra
ti
o
 i
s 
m
o
re
 t
h
an
 
6
d
B
 (
R
o
b
in
et
te
 &
 G
la
tt
k
e,
 2
0
0
2
).
 I
n
 s
it
u
at
io
n
s 
w
h
er
e 
n
o
is
e 
le
v
el
s 
ar
e 
lo
w
 a
n
d
 t
h
e 
ra
ti
o
 i
s 
m
o
re
 t
h
an
 6
d
B
 i
t 
m
a
y
 b
e 
p
o
ss
ib
le
 t
o
 m
is
s 
a 
h
ea
ri
n
g
 l
o
ss
 d
u
e 
to
 l
ev
el
 o
f 
th
e 
si
g
n
al
 (
R
o
b
in
et
te
 &
 G
la
tt
k
e,
 2
0
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Tympanograms were classified as being A, As, Ad, B or C (Clark et al., 2008; Roeser et 
al., 2007) (Table 8). 
 
Table 8 
 
Classification of Tympanograms 
 
Classification 
of 
Tympanogram 
Ear Canal 
Volume 
(ml
3)
 
Static 
Admittance 
(mmho/ml
3
 ) 
Peak Pressure 
(daPa) 
Clinical Finding 
Type A 0.6-1.5 0.3 - 1.4 +50 to -150 Normal middle ear function 
Type As 0.6-1.5 < 0.3 +50 to -150 Stiffness on the middle ear 
system 
Type Ad 0.6-1.5 > 1.4 + 50 to -150 Disarticulation in the middle 
ear ossicles 
Type B >1.5 < 0.3 No peak Pathological condition with 
possible perforated tympanic 
membrane 
Type B 0.6-1.5 < 0.3 No peak Restricted tympanic 
membrane mobility 
Type C 0.6-1.5 0.3 – 1.4 -150 and higher Significant negative pressure 
in the middle ear cavity 
 
 
The degree of hearing loss of participants was classified utilizing the World Health 
Organization grading system for hearing impairment as described by Mathers et al. (2000). Table 
9 provides the World Health Organization’s grades of hearing impairment utilized in the study. 
 
Table 9 
 
World Health Organization’s Grades of Hearing Impairment 
 
Grade of Impairment Audiometric ISO Value 
0 (no impairment) 25dB HL or less 
1 (slight/mild impairment) 26-40dB HL 
2 (moderate impairment) 41-60dB HL 
3 (severe impairment) 61-80dB HL 
4 (profound impairment including 
deafness) 
81dB HL or greater 
Note. dB HL=decibels hearing level 
 
3.4.4  Infection control 
Precautions regarding infection control not only reduce but also prevent healthcare 
associated infections (Garcia-Zapata et al., 2010). Stringent hand hygiene and precautions when 
utilizing equipment is therefore recommended for safe practice (Garcia-Zapata et al., 2010). The 
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researcher therefore washed her hands prior to the audiological evaluation of each participant, 
utilized Dismed D-Germ alcohol antiseptic hand rub when necessary and utilized latex gloves 
when necessary. Different specula were also utilized for each ear (for each participant) for 
hygiene purposes. Milton sterilising fluid was utilized on all specula to disinfect them prior to 
use. The earphones, bone conductor and response button were disinfected with Webcol alcohol 
prep pads prior to use for each participant. 
3.4.5  Data collection procedures 
The procedure used during the research process are described below. 
 
Ethical clearance was obtained from the University of Witwatersrand Human Research 
Ethics Committee (Certificate number: M10736) (Appendix D). Once ethical clearance was 
obtained, permission was requested from the chief executive officers of the Charlotte Maxeke 
Johannesburg Academic Hospital (Appendix E) and South Rand Hospital (Appendix F) 
respectively. 
On confirmation of permission, a pilot study was conducted at South Rand Hospital with 
four individuals who met the selection criteria. The results of these individuals were not included 
in the main study. Once the modifications from the pilot study were complete, the researcher 
recruited participants for the main study. 
The researcher attended the Out Patient Department at South Rand Hospital and the 
Cardiology Clinic at Charlotte Maxeke Johannesburg Academic Hospital. With the doctors’ and 
cardiologists’ assistance, potential participants for the study were identified. These individuals 
were approached by the researcher who presented them with a participant information sheet 
(Appendix B). Individuals who were unable to read and/or write were provided with the 
information verbally.  
Individuals who were willing to participate were required to complete a consent form 
(Appendix B). Participants who were unable to read and/or write confirmed their consent with a 
thumb print.  
Once participant consent was obtained, the researcher completed the questionnaire with 
all participants (Appendix A). The information obtained in the case history further determined if 
an individual met the criteria for inclusion in this study.  
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Once the case history form was completed by the researcher and it was determined that 
an individual met the selection criteria, an appointment was made to conduct an audiological 
evaluation at the South Rand Hospital Audiology Department at a time that was suitable for the 
participant. For the 43 participants who were obtained at the Out Patient Department at South 
Rand Hospital, the audiological evaluation was conducted immediately or on the same day. 
On completion of the audiological evaluation, participants were provided with feedback 
regarding the results of the evaluation. Two participants contacted the researcher after their 
audiological evaluation to request that feedback be provided to a spouse or family member. 
For participants who required further audiological management, a follow-up appointment 
was made at South Rand Hospital or they were referred to a facility/institution that was more 
convenient for them. Participants who required medical intervention were referred accordingly. 
These participants were provided with a report of their audiological results (Appendix G).  
After the audiological evaluation, participants were thanked verbally and provided with a 
packet of sweets as a token of appreciation. 
All participants who utilized their own transport to attend their appointment for the 
audiological evaluation were offered R50.00 as compensation; however, only five participants 
accepted the remuneration.  
Once the audiological evaluation was completed, data was captured, encoded and 
analysed using various statistical measures. 
3.4.6  Reliability and validity 
3.4.6.1  Reliability 
Reliability is the “degree to which a procedure for measuring produces similar outcomes 
when it is repeated” (Baker, 1994, p. 127). It refers to the consistency or the stability of research 
findings (Rosnow & Rosenthal, 2006). There are different types of reliability, two of which are 
equivalent forms reliability and inter-rater reliability: 
• Equivalent forms reliability is imperative as participants were assessed only once in this 
study (Baker, 1994). Equivalent forms reliability concerns determining the degree to which 
results are consistent (Huck, 2008). This form of reliability utilizes two different measures 
to determine the same/similar result (Bless, Higson-Smith, & Kagee, 2007). Equivalent 
forms reliability can be established using the cross-check principle. The cross-check 
principle is the process whereby the results of one test are compared to another 
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independent measure (Jerger & Hayes, 1976; Turner, 2003). In this study the speech 
reception threshold was compared to the pure tone average, as both procedures assess the 
lowest intensity at which participants can hear a sound (tone or speech sounds). A 
correlation between the speech reception threshold and the pure tone average of 8dB or 
less is considered to be indicative of reliable results (Bluestone, 2003; Hergenreder & 
Tang, 1992). 
• Inter-rater reliability is the degree of consistency of two or more individuals recording the 
same results for the same procedure (Huck, 2008; Rosnow & Rosenthal, 2006). This is 
usually implemented by having an impartial individual observe and record results for 
approximately 15% of the experiments/evaluations after which a reliability co-efficient is 
calculated (Spata, 2003). The researcher ensured that 20% (n = 18) of the audiological 
evaluations were observed and independently recorded by another audiologist, thus 
contributing to inter-rater reliability. The other audiologist had eight years clinical 
experience in conducting audiological evaluations. Once the impartial audiologist had 
observed and independently recorded 20% of the audiological evaluations, inter-rater 
reliability was calculated as a percentage utilizing the following formula (Jackson, 2009): 
 
Inter-rater reliability (%) = (Number of agreements/Number of possible agreements) x 100 
 
The number of agreements refers to the number of observations/recordings in which both 
raters have documented/recorded the same result (Jackson, 2009). The number of 
possible agreements refers to the total number of observations/recordings (Jackson, 
2009). Throughout the audiological evaluation, a total of 48 agreements were possible. 
The sum of 48 comprised observations for otoscopic examination, tympanometry, pure 
tone audiometry, pure tone average and speech audiometry. Table 10 provides the 
point/agreement allocation for each audiological procedure. 
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Table 10 
Point Allocation for each Audiological Procedure for Inter-Rater Reliability 
Number of points/agreements 
(including right ear and left ear) 
Audiological 
procedure 
Components 
Right ear Left ear 
Otoscopic 
examination 
Otoscopic Examination 1 1 
Tympanometry Tympanogram 1 1 
Air conduction testing 
(each test frequency) 
6 6 
Bone conduction testing 
(each test frequency) 
5 5 
Pure tone 
Audiometry 
 
Pure tone average 1 1 
Speech reception threshold 1 1 
Most comfortable level 1 1 
Uncomfortable loudness level 1 1 
Dynamic range 1 1 Speech audiometry 
Speech discrimination  
(including level of presentation and 
result obtained) 
6 6 
Total per ear  24 24 
Total number of 
possible agreements 
  
48 
 
 
The number of agreements for all 18 participants was added and the sum of 792 
agreements was obtained out of a possible 864. This resulted in an inter-rater reliability of 92% 
indicating a very good inter-rater reliability (Jackson, 2009). 
 The reliability of the study was further improved as the criteria, the researcher, data 
collection procedure (test protocol) and the instrumentation used was the same for all 
participants in this study, thus enhancing consistency. The measures utilized during the 
audiological evaluation were standardized procedures which were repeatable, thus contributing 
to reliability. 
3.4.6.2  Validity 
Validity is the degree to which research results are accurate (Baker, 1994; Huck, 2008). 
Audiologically, this refers to the ability of a test to detect the disorder for which it was designed 
(Roeser et al., 2007). There are many different types of validity; however, the two types most 
appropriate for this study were face validity and content validity. 
Face validity refers to the degree to which an instrument/procedure measures what it 
intends to measure (Rosnow & Rosenthal, 2006). The researcher gave the participant 
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questionnaire to two qualified audiologists for critique. The two audiologists had six years and 
four years clinical experience respectively. The two audiologists were, therefore, knowledgeable 
regarding the content of audiology case history questionnaires and modifications were made 
based on their recommendations. Both audiologists agreed that the questions in the participant 
questionnaire were relevant to the study and allowed for specificity and sensitivity regarding 
participant criteria. This enhanced face validity since the participant questionnaire was in 
accordance with the aims of the study. 
Content validity is the accuracy of procedures and equipment to measure what they claim 
to measure (Baker, 1994). Calibration of equipment ensures accurate functioning of equipment, 
thus contributing to the validity of results. All the equipment utilized in the study has been 
recently calibrated. Calibration standards were in accordance with those prescribed by the South 
African National Standards (2004) (SABS 0154-1; 0154-2), thereby ensuring that the results 
were accurate and valid (Appendix H). Furthermore, a pilot study was conducted on four 
individuals who met the participant selection criteria. This allowed for further modifications to 
be made, thus enhancing content validity in this study. 
3.5 Ethical Considerations 
In 1964, the World Medical Association developed the Declaration of Helsinki. This 
declaration was a set of ethical principles for researchers involved in medical research in human 
beings (World Medical Association, 2008). The principles are aimed at promoting the safety and 
well-being of the patient (World Medical Association, 2008). The following principles were 
adhered to in this study: 
• Submission of research protocols for consideration and approval (World Medical 
Association, 2008). A research proposal was submitted for ethical clearance to the 
Human Research Ethics Committee (Medical) at University of Witwatersrand 
(Certificate number: M10736) (Appendix D). Only once ethical clearance was 
obtained did the study proceed. Furthermore, consent was obtained from South Rand 
Hospital (Appendix F) and Charlotte Maxeke Johannesburg Academic Hospital 
(Appendix E) to obtain participants from those sites. 
• Participation in medical research should be voluntary (World Medical Association, 
2008). Informed consent was obtained from all participants. Individuals willing to 
participate in this study were required to complete a consent form and only 
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participants who met the selection criteria were included in the study. Participants 
were made aware that should they decide not to participate, or decide to withdraw at 
a later stage; no penalty would be incurred. They also had the right to refuse to 
answer any particular question/s should they wish. 
• Human subjects should be informed of the aims, methods and potential risks of the 
study and possible discomfort which it may entail (World Medical Association 
2008). Participants were provided with an information sheet which outlined the 
nature of this study, risks and benefits, the procedures and informed participants of 
their right to withdraw. 
• Precautions should be taken to protect the privacy of research subjects and 
confidentiality regarding personal information should be assured (World Medical 
Association, 2008). The privacy of participants in this study was considered at all 
times during and after the data collection process. The participant questionnaire was 
completed in a private setting, free from interruptions and onlookers. This ensured 
confidentiality. Anonymity of participants should be ensured from the beginning to 
ensure confidentiality (Meline, 2006). As each participant was assessed in person, 
complete anonymity could not be guaranteed. The researcher did, however, maintain 
confidentiality by not including any identifying information in the research report. 
Once data was collected, it was coded utilizing participant numbers only. Raw data 
(containing identifying information) was kept separate from coded data and was 
stored in a locked cupboard in the researcher’s residence for the duration of the 
study. Thereafter the raw data will be stored in a locked cabinet in the Department of 
Speech Pathology and Audiology at the University of Witwatersrand for a period of 
five years. After this period, the raw data will be destroyed. 
• Medical research must be conducted by individuals with appropriate training and 
qualification (World Medical Association, 2008). The researcher is a qualified 
audiologist with seven years experience clinical experience in the field of Audiology. 
She therefore has appropriate skills and knowledge to conduct the audiological 
evaluations on the participants in this study. 
•  Prior to commencement of a study, risks need to be assessed and satisfactorily 
managed (World Medical Association, 2008). The risks associated with an 
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audiological evaluation include only a small possibility of temporary discomfort. The 
participants were, nonetheless, provided with the researcher’s 24-hour contact 
number should they had any queries. 
• Subjects should incur a minimal burden through participation (World Medical 
Association, 2008). Participants who were not regular patients at South Rand 
Hospital and who utilized their own means of transport to get to the hospital were 
offered R50.00 financial compensation for travel expenses on the day of testing. This 
was done to reduce the inconvenience to participants and to reduce the burden of 
additional costs. For individuals who did not meet the selection criteria but still 
requested an audiological evaluation, an appointment was made at the South Rand 
Hospital. Alternatively, if they preferred, they were referred to a facility that was 
more convenient for them.  
3.6 Analysis of Data 
Data were captured and encoded for analysis according to the data definitions. The 
researcher analysed the data to determine the characteristics of the variables and to determine if 
the hypothesis had been proven (Dietz & Kalof, 2009). All the data was computerized for 
statistical analysis on an MS Excel spreadsheet and the XLSTAT (XLSTAT Software, 1995) 
statistical analysis program (XLSTAT Software, 1995). The results were then analysed using a 
variety of statistical procedures and displayed in tables and figures.  
The researcher employed content analysis, descriptive statistics and parametric measures 
to analyse the data as data was normally distributed. 
Content analysis provides categorical data which lends itself to quantification (Breakwell, 
2000). Once the data was collected, similarities or themes were identified (for instance, the 
number of participants who shared the same biographical information, medical information, 
audiological information, recommendations). Descriptive analysis allows for the description of 
quantitative data by calculating means, standard deviations and the range (Babbie, 2010). In this 
study the mean, median and mode was calculated for each test frequency on the audiogram for 
all possible combinations of analysis (for example entire sample, age, male/female, type of 
cardiovascular disease and the duration of the disease). The mean, standard deviation and range 
was also calculated for speech reception threshold results and for the results of otoacoustic 
emissions for each frequency. 
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Various parametric statistical analysis measures were utilized to analyse the data. These 
included one-tailed t-tests, two-tailed t-tests and an analysis of co-variance. One-tailed t-tests are 
parametric measures which utilize a hypothesis to compare the mean score of a sample against a 
normative value or mean (Bland, 2001; Dalgaard, 2008). This test was appropriate for this study, 
since the aim of the study was to determine if there was a significant difference in the hearing 
abilities of individuals with cardiovascular disease compared to those without the disease. This t-
test enabled the researcher to analyse the pure-tone results and to compare them to the norms for 
normal hearing. This t-test also allowed for the comparison of subgroups within the sample to be 
compared to the norms (for example participants with coronary artery disease/cardiomyopathy, 
males, and females). 
A two-tailed t-test compares the mean of two samples and determines if the differences 
between the two are statistically significant (Steinberg, 2011). Two-tailed t-tests are often 
utilized to compare males and females or to compare two different test groups with the null 
hypothesis. In this study, the two-tailed t-tests were utilized to compare males to females and 
participants with coronary artery disease to participants with cardiomyopathy. 
An analysis of co-variance is a technique which lies between analysis of variance and 
regression analysis. It is a form of multiple linear regression which is also known as the general 
linear model (Howell, 1997). Analysis of co-variance allows for precise comparisons between 
groups by accounting for the variation of important prognostic variables (for example when 
comparing two linear regression lines) (Borm, Fransen, & Lemmens, 2007). As opposed to other 
methods of data analysis for quantitative analysis, the analysis of co-variance has three variables: 
the independent variable, the dependent variable and the co-variate. In this study, the dependent 
variable was the hearing level at each frequency and the independent variable was cardiovascular 
disease. The co-variants were age, gender and duration of cardiovascular disease. The analysis of 
co-variance calculated the degree to which age, gender and duration of the disease impacted on 
hearing in individuals with this disease. It also calculated the combination of these variables and 
the statistical probability of each combination influencing hearing in individuals with the disease. 
A confidence level of 99% (α=0.01) was utilized for all tests. Confidence levels reduce 
the uncertainty of the results obtained during the data analysis process (Siegel, 2012). 
Confidence levels therefore determine the success rate of the test being utilized (Moore, 2010). 
Whilst 95% is commonly utilized when analysing data, a confidence level of 99% is 
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recommended in medical research as it allows for surety of results. A 99% confidence level is 
also recommended for large samples as this reduces the probability of results being attributed to 
deviations and random errors (Siegel, 2012). The use of a 99% confidence level was therefore 
appropriate for this study. 
3.7 Conclusion 
This chapter described the methodology of the research. It included the aim of the 
research and a description of the research design and phases. A description of the pilot study that 
indicated problem areas and recommendations followed. The main study was discussed with 
respect to participant selection criteria and description, as well as equipment and measuring 
instruments. Finally data collection procedures and analysis were discussed. 
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CHAPTER 4 
 
RESULTS 
 
4.1 Introduction 
 
The results of the study are presented in this chapter in relation to the aims of the study. 
This chapter commences with a description of the audiological findings after which the four 
independent variables are discussed. Data was organized, analysed and interpreted with a view 
on drawing conclusions regarding the prevalence of hearing loss in individuals with the disease. 
4.2 Description of the Audiological Findings 
4.2.1  Case history according to participant questionnaire  
The participant questionnaire provided relevant information about participants’ 
perception of their hearing abilities. The primary complaint of many participants was difficulty 
hearing in noise. Forty percent of the participants (n = 44) reported that they experience hearing 
difficulties. This included difficulty hearing in noise (n = 32), difficulty hearing in all situations 
(n = 10), and difficulty hearing female voices (n = 2). Figure 1 illustrates the percentage of 
participants who reported each type of difficulty. 
 
Nature of Hearing Loss
Women are 
difficult to hear
5%
Difficulty with 
all sounds
23%
Difficulty in 
noise
72%
 
Figure 1. The percentage of participants who reported each type of hearing difficulty 
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These participants also indicated the laterality of the hearing difficulties they experience. 
Twenty three percent (n = 10) reported the right ear to be worse, 16% (n = 7) reported the left ear 
to be worse, whilst 61% (n = 27) reported the hearing ability of both ears to be similar. 
The onset of the hearing difficulties prior to testing in this study ranged between one and 
three years. Sixty one percent of participants (n = 27) reported experiencing hearing difficulties 
for between one and two years and 39% (n = 17) reported experiencing hearing difficulties for 
two to three years. Sixteen percent (n = 7) of the participants who reported hearing difficulties 
stated that their hearing had deteriorated since being diagnosed with cardiovascular disease.  
Thirty four percent of the participants (n = 31) reported experiencing tinnitus. Of these 
participants all reported experiencing constant, high frequency tinnitus bilaterally. Sixty one 
percent (n = 19) reported their tinnitus to be worse in the morning, whilst 39% (n = 12) reported 
it to be worse at night prior to going to sleep. Other difficulties reported by some participants 
included asthma, arthritis and/or visual difficulties. 
4.2.2  Otoscopic examination 
An otoscopic examination revealed that the majority of participants (73%; n = 67 in the 
right ear and 78%; n = 72 in the left ear) presented with unobstructed ear canals and healthy 
tympanic membranes. Partially occluding, soft cerumen was observed in 27% (n = 25) of 
participants in the right ear and in 22% (n = 20) in the left ear. The presence of the cerumen did 
not interfere with the audiological evaluation. Of the 92 participants, three presented with 
impacted cerumen. They were referred to the Out Patient Department at South Rand Hospital for 
management. The cerumen was removed, after which the audiological evaluation was conducted. 
4.2.3  Immittance audiometry 
Immittance audiometry comprised tympanometry and ipsi-lateral acoustic reflexes. The 
tympanometry results indicated that 99% (n = 91) and 96% (n = 88) of participants presented 
with a normal type A tympanogram in the right ear and left ear respectively. Type C 
tympanograms were recorded for one percent (n = 1) and four percent (n = 4) in the right ear and 
left ear respectively. Participants with type C tympanograms were included from the study. 
These results indicate that middle ear pathology does not significantly contribute to hearing loss 
in adults with cardiovascular disease. 
The results of the ipsi-lateral acoustic reflexes are presented in Table 11. Only the results 
of the participants who obtained acoustic reflexes at each test frequency in the right ear and the 
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left ear are provided. Normal acoustic reflexes thresholds are between 85dB and 100dB, whilst 
acoustic reflexes thresholds greater than 100dB are considered to be elevated (Gelfand, 2009) 
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None of the participants obtained acoustic reflexes less than 85dB bilaterally. The 
difference between the percentage of participants who obtained acoustic reflexes in the right ear 
and the left ear ranges from one percent (at 500Hz) to nine percent (at 4000Hz). The average of 
the reflexes increased bilaterally with each frequency. The average was greater than 100dB for 
4000Hz in the right ear and 1000Hz, 2000Hz and 4000Hz in the left ear. The percentage of 
participants who obtained a reflex greater than 100dB also increased with each test frequency 
and the percentage of participants who obtained a reflex greater than 100dB was higher in the 
left ear at 1000Hz, 2000Hz, and 4000Hz.  
4.2.4  Pure tone audiometry 
4.2.4.1 Air conduction 
Air conduction thresholds were obtained for all participants. Thresholds less than 25dB 
are considered to be within normal limits. Thresholds greater than 25dB are considered elevated 
and indicate some degree of hearing impairment (Mathers et al., 2000). A difference of 10dB or 
less between air conduction and bone conduction thresholds (at each frequency) is indicative of a 
sensorineural hearing loss only if both thresholds are greater than 25dB. A difference of more 
than 10dB indicates a conductive/mixed component (Roeser et al., 2007). 
More than 60% of participants obtained all air conduction thresholds less than 25dB, 
indicating normal hearing in those participants (Table 12). 
Table 12 
Results of Participants with Normal Air Conduction Thresholds at All Test Frequencies 
 
 Air Conduction Thresholds % (n) 
 Right Ear Left Ear Bilateral 
All thresholds <25dB 64 (58) 55 (51) 66 (61) 
 
Air conduction results revealed that many participants presented with hearing within 
normal limits for all but one frequency. Average thresholds less than 25dB were obtained at 
500Hz, 1000Hz, 2000Hz, 4000Hz and 8000Hz in both ears. The average threshold for 250Hz 
was 36.25dB in the right ear and 28.10dB in the left ear. Sixty three percent of participants (n = 
58) obtained a threshold of more than 25dB at 250Hz in the right ear and 55% (n = 51) in the left 
ear. Thirty eight percent of participants (n = 35) obtained a threshold greater than 25dB at 500Hz 
in the right ear and fifty percent (n = 46) in the left ear. The percentage of participants who 
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obtained thresholds greater than 25dB decreased with each frequency octave. This proves that 
the participants in this sample presented with a low frequency hearing loss.  
The average of the pure tone average was 20.27dB for the right ear and 17.71dB for the 
left ear (Table 13). Although this was less than 25dB bilaterally, 11% of participants (n = 10) 
obtained a pure tone average greater than 25dB in the right ear and five percent (n = 5) in the left 
ear. This indicates that the prevalence of hearing loss in this population is 11% in the right ear 
and five percent in the left ear. Of the 11% who presented with an elevated pure tone average in 
the right ear, 50% (n = 5) presented with a moderate hearing loss and 50% (n = 5) presented 
with a mild hearing loss. All participants who presented with an elevated pure tone average in 
the left ear presented with a mild hearing loss. 
A one-tail t-test was conducted at each frequency for air conduction thresholds to 
determine if the difference between the average threshold obtained and the norm of 25dB is 
statistically significant. The null hypothesis being tested was, the sample has normal hearing. 
The alternate hypothesis was that the sample has impaired hearing (that is, the mean of the 
sample is significantly greater than 25dB). The p-value determined if the null hypothesis was 
rejected. At 250Hz in the right ear, a p-value of <0.0001 was obtained. This implies that the 
difference between the average of the sample, when compared to normal hearing thresholds, was 
statistically significant at 250Hz in the right ear. The null hypothesis was, therefore, rejected at 
that frequency. The differences were deemed not significant at all other frequencies in the right 
ear and at all test frequencies in the left ear; and the null hypothesis was, therefore, not rejected. 
While the t-test results did not reject the null hypothesis at any other test frequencies and the 
difference between participants’ averages and the norm were deemed statistically insignificant, 
38% of participants (n = 35) obtained a threshold greater than 25dB in the right ear and 23% of 
participants (n = 21) in the left ear at 500Hz for air conduction thresholds. The standard 
deviation was higher in the low frequencies in both the right ear and the left due to an increase in 
the range. The air conduction thresholds, pure tone audiometry and t-test results are presented in 
Table 13. 
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4.2.4.2  Bone conduction 
The percentage of participants who presented with normal bone conduction 
thresholds at all test frequencies is presented in Table 14. The average bone conduction 
threshold for 250Hz in the right ear was greater than 25dB and the average in the left ear 
was less than 25dB. Sixty two percent of participants (n = 57) obtained a threshold 
greater than 25dB at 250Hz in the right ear compared to 50% of participants (n = 46) in 
the left ear. 
 
Table 14 
Results of Participants with Normal Bone Conduction Thresholds at All Test Frequencies 
 Bone Conduction Thresholds %(n) 
 Right Ear Left Ear Bilateral 
All thresholds <25dB 62(57) 50(46) 66(61) 
Note. dB=decibel 
 
 Thirty three percent of participants (n = 30) obtained a threshold greater than 
25dB at 500Hz in the right ear compared to 11% of participants (n = 10) in the left ear, 
resulting in a difference of more than 20%. The percentage of participants who obtained 
thresholds greater than 25dB decreased with each frequency octave, indicating a low 
frequency sensorineural hearing loss.  
More than 60% of participants obtained thresholds less than 25dB at all test 
frequencies, indicating normal hearing in those participants.  
A one-tail t-test was conducted at each frequency for bone conduction thresholds 
to determine if the difference between the average threshold obtained and the norm of 
25dB is statistically significant. At 250Hz in the right ear, a p-value of 0.0003 was 
obtained. This implies that the difference between the averages of the sample compared 
to normal hearing thresholds was statistically significant at 250Hz in the right ear. The 
null hypothesis that the sample has normal hearing for bone conduction thresholds in the 
right ear was, therefore, rejected at 250Hz. At all other frequencies the differences were 
deemed not significant in both the right ear and the left ear. The null hypothesis was, 
therefore, not rejected. While the t-test results did not reject H0 at all other test 
frequencies and the difference between participants’ averages and the norm were deemed 
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statistically insignificant, 50% of participants (n = 46) obtained thresholds greater than 
25dB at 250Hz in the left ear. The average thresholds for the bone conduction results and 
the results of the t-tests are presented in Table 15. 
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4.2.4.3  Air conduction and bone conduction 
All bone conduction thresholds were less than air conduction thresholds for all 
participants at all test frequencies. The difference between air conduction and bone 
conduction thresholds range between 0dB and 10dB indicating a sensorineural hearing 
loss. The difference in averages between air conduction and bone conduction thresholds 
is presented in Figure 2 (right ear) and Figure 3 (left ear). 
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Figure 2. The range (in dB) and the average (in dB) for air conduction and bone 
conduction thresholds at each test frequency in the right ear 
  
70
0
5
10
15
20
25
30
35
40
45
50
55
250Hz 500Hz 1000Hz 2000Hz 4000Hz 8000Hz
Frequency (Hz)
In
te
n
s
it
y
 (
d
B
H
L
) AC (avg)
AC (min)
AC (max)
BC (avg)
BC (min)
BC (max)
 
Figure 3. The range (in dB) and the average (in dB) for air conduction and bone 
conduction thresholds at each test frequency in the left ear 
 
 
The average difference between air conduction and bone conduction thresholds is less 
than 6dB for all test frequencies bilaterally. The difference between air conduction and 
bone conduction thresholds ranged from 0dB to 15dB with the biggest range of 15dB 
recorded at 250Hz in the right ear. Only one participant presented with a difference of 
15dB, indicating a conductive hearing loss in the right ear at 250Hz. The remaining 
participants who presented with elevated thresholds presented with a low frequency 
sensorineural hearing loss. The difference in averages is presented in Table 16. 
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4.2.5  Speech audiometry 
Speech audiometry comprised speech reception threshold, most comfortable level, 
uncomfortable loudness level, the dynamic range (n = 10) and speech discrimination 
levels. The average, standard deviation, minimum value, maximum value, the range and 
the mode was calculated for each component of speech audiometry. In addition, the 
correlation between the speech reception threshold and the pure tone average was 
calculated. Table 17 presents the results for the speech reception threshold, the most 
comfortable level, the uncomfortable loudness level, dynamic range and the difference 
between the speech reception threshold and the pure tone average. 
The average speech reception threshold in the right ear was 3.1dB more than the 
speech reception threshold in the left ear. Both the right ear and the left ear had a range of 
35dB for the speech reception threshold. The average most comfortable level was 26.9dB 
more than the speech reception threshold in the right ear and 30.32dB in the left ear. The 
average most comfortable level was between 25-30dB greater than the average for speech 
reception threshold even for participants with elevated pure-tone thresholds. The most 
comfortable level falls between 40-55dB greater than the speech reception threshold 
(Kaplan et al., 1993). The most comfortable levels fell less than 40dB for 10% of 
participants (n = 10) in the left ear. None of the participants presented with a most 
comfortable level of less that 40dB in the right ear. A low most comfortable level (when 
compared to the speech reception threshold) is suggestive a cochlear site of lesion 
(Kaplan et al., 1993). 
The range of uncomfortable loudness level in the right ear and the left ear was 
equal (10dB). The average uncomfortable loudness level was 75dB higher than the 
speech reception threshold in the right ear and 76dB in the left ear. The average 
difference between the speech reception threshold and pure tone average was less than 
5dB bilaterally with the range being 5.1dB higher in the left ear. Seventeen percent of 
participants (n = 16) reported their uncomfortable loudness level to be beyond the limits 
of the audiometer. As a result, the dynamic range for those participants could not be 
calculated. Speech discrimination at the last level (uncomfortable loudness level minus 
10dB) could also not be conducted for those participants. The results in Table 17 exclude 
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those participants in the analysis for uncomfortable loudness level, dynamic range and 
level 3 for speech discrimination. 
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The dynamic range for individuals with normal hearing is 80-100dB (Roeser 
Valente, & Hosford-Dunn, 2000). The average dynamic range for participants in this 
study was 70dB in the right ear and 61dB in the left ear. This indicated a reduced 
dynamic range for the participants with a low frequency hearing loss in this study. 
None of the participants presented with rollover bilaterally. The results for speech 
discrimination testing are presented in Table 18. 
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Significant rollover is seen in individuals with retro-cochlear pathology and in 
neural presbycusis (Gelfand, 2009; Kaplan et al., 1993). Individuals with cochlear 
pathology present with no decline or less than 20% decline as intensity increases (Roeser 
et al., 2000). Participants in this study, therefore, did not present with a hearing loss 
which was caused by retro-cochlear pathology and the results indicate that the pathology 
may be cochlear in nature. 
4.2.6  Distortion product otoacoustic emissions 
Distortion product otoacoustic emissions were tested at 750Hz, 1000Hz, 2000Hz, 
3000Hz, 4000Hz, 6000Hz and 8000Hz bilaterally. The average, standard deviation, 
minimum, maximum, range, mode and percentage of participants who passed this test 
were calculated at each test frequency for the right ear and the left ear. Table 19 provides 
the results for the distortion product otoacoustic emissions for each ear.  
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The difference between the average at 750Hz for the right ear and for the left ear 
is 1.58dB, with the right ear being worse. The range decreased with each increasing 
octave with 750Hz having the biggest range bilaterally. Sixty six percent of participants 
(n = 61) passed all test frequencies bilaterally, 70% (n = 64) passed all test frequencies in 
the right ear and 77% (n = 71) passed all test frequencies in the left ear.  
A two-tailed t-test was conducted to compare the difference between distortion 
product otoacoustic emissions in the right ear to those in the left ear at each test 
frequency. The null hypothesis was, there is no difference between distortion product 
otoacoustic emissions in the right ear and in the left ear. The alternate hypothesis was that 
there is a difference between distortion product otoacoustic emissions in the right ear and 
the left ear. Table 20 provides the results at each test frequency in the right ear and left 
ear. 
 
Table 20 
 
Results of the two-tailed t-Test comparing Distortion Product Otoacoustic Emissions in 
the Right Ear and Left Ear 
 
 750Hz 1000Hz 2000Hz 3000Hz 4000Hz 6000Hz 8000Hz 
P-Value 0.0001* <0.0001* 0.0009* <0.0001* 0.1659 0.30062 0.1648 
Note. *= significant difference at a confidence level of 99%. 
 
Results from t-test revealed that the null hypothesis, namely, that the distortion 
product otoacoustic emissions in the right ear and the left ear would be equal, was 
rejected at 750Hz, 1000Hz, 2000Hz and 3000Hz, indicating a significant difference 
between the right ear and the left ear at those frequencies. 
As distortion product otoacoustic emissions provide frequency specific 
information based on discrete frequency stimuli, they are often compared to audiometric 
configurations. In individuals with sensorineural hearing loss, distortion product 
otoacoustic emissions often reduced or eliminated only for the stimulus frequency regions 
which coincide with the impaired region (Gaskill & Brown, 1990; Stover, Gorga, Neely, 
& Montoya, 1996). The correlation between pure tones and distortion product otoacoustic 
emissions was, therefore, calculated to determine a possible relationship between pure 
tone values and the emissions. A standard correlation co-efficient was calculated for 
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1000Hz, 2000Hz, 4000Hz and 8000Hz for pure tones and distortion product otoacoustic 
emissions. A correlation co-efficient was also calculated comparing 500Hz (pure tones) 
and 750Hz (distortion product otoacoustic emissions). Table 21 provides the correlation 
co-efficient at each frequency and for 500Hz/750Hz for the right ear and left ear. 
 
Table 21 
 
The Correlation Co-efficient (between Pure Tones and Distortion Product Otoacoustic 
Emissions) at Each Frequency and for 500Hz-750Hz for the Right Ear and the Left Ear 
 
 r 
 500/750Hz 1000Hz 2000Hz 4000Hz 8000Hz 
Right ear -0.791 -0.729 -0.591 -0.433 -0.416 
Left ear -0.730 -0.601 -0.249 -0.520 0.007 
Note. r= correlation co-efficient; Hz=hertz 
 
The correlation co-efficient in the right ear decreased as the frequency increased. 
The correlation between pure tones and distortion product otoacoustic emissions is 
therefore higher in the low frequencies in the right ear (Figures 4, 5, 6 and 7). The 
positive correlation was obtained at 8000Hz in the left ear. A negative correlation 
indicates an increase in one variable as the other variable decreases (Surhone, Timpledon, 
& Marseken, 2010). A negative correlation was obtained at all other test frequencies 
indicating a decrease in emissions as pure tone values increase. The correlation co-
efficient was highest at 500/750Hz (Right Ear: r = -0.791, Left Ear: r = -0.730) and at 
1000Hz (Right Ear: r = -0.729, Left Ear: r = -0.601). A correlation coefficient between 
0.7 and 0.9 is considered strong/high and a correlation coefficient between 0.4 and 0.7 is 
considered to be moderate (Surhone et al., 2010). The negative correlation at 250Hz in 
the right and left ear and at 100Hz in the right ear was therefore high. 
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Distortion product otoacoustic emissions of participants in the current study 
revealed the low frequencies to be affected. Low frequency involvement indicated the 
apex of the cochlear to be a possible site of lesion (Kros & Evans, 2006; Stach, 1998). 
4.2.7  Summary of audiological findings 
The results of the audiological evaluation revealed the outer and middle ear to have 
minimally influenced hearing thresholds in this sample. Pure tone results revealed that 
participants presented with a low frequency sensorineural hearing loss. Speech 
discrimination results and distortion product otoacoustic emissions results confirmed a 
possible site of lesion to be the cochlea. The prevalence of bilateral hearing loss was five 
percent (n = 4). The prevalence of unilateral hearing loss was 11% (n = 10) in the right 
ear and five percent (n = 5) in the left ear. Of the 11% of the participants who presented 
with a hearing loss in the right ear, half presented with a moderate hearing loss whilst the 
other half presented with a mild hearing loss. All 5% of participants who obtained a pure 
tone average of greater than 25dB in the left ear presented with a mild hearing loss. This 
revealed that the prevalence of hearing loss in the current study may be higher in the right 
ear as they presented with more elevated thresholds in the right ear than the left ear. 
4.3 Independent Variables 
The four independent variables in this study were (i) age, (ii) gender, (iii) 
diagnosis and (iv) duration of cardiovascular disease. The correlation co-efficient was 
calculated and t-test were conducted for these variables. In order to determine the 
influence of these variables on hearing thresholds and to determine the interaction 
between these variables and their impact on hearing thresholds an analysis of co-variance 
was further conducted. 
4.3.1   Age 
The ages of the 92 participants ranged from 40 years to 54 years and zero months 
(average: 48 years and five months; standard deviation: 3.70). Forty percent of 
participants (n = 37) were between 45 years and 48 years and 11 months of age. Figure 8 
illustrates the number of participants in three age categories: 40 to 44 years, 45 to 49 
years and 50 to 55 years. 
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Sample Split into Age Categories
35 participants
37 participants
20 participants
40 to 44 years 45 to 49 years 50 to 55 years
 
Figure 8. The number of participants between the ages of 40 and 44 years, 45 and 49 
years and, 50 and 55 years 
 
Of the 37 participants aged between 45 years and 49 years, 12 participants were 
49 years old and 10 participants were 45 years of age. Figure 9 illustrates the age 
distribution of participants (rounded to the nearest year). 
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Figure 9. The age distribution of participants (rounded to the nearest year) 
 
4.3.2  Gender 
The study included 92 participants: 60 males and 32 females. 
4.3.2.1 Males 
The average at 250Hz for air conduction and bone conduction thresholds in the 
right ear were greater than 25dB, whilst the left ear it was less than 25dB (Table 13 and 
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Table 15). The difference in the average between air conduction and bone conduction 
ranged from 3.16dB to 6.09dB in the right ear and from 3.59dB to 4.75dB in the left ear 
(Table 16). The average of air conduction and bone conduction thresholds decreased with 
each frequency.  
Air conduction results revealed that 37 males had a threshold greater than 25dB at 
250Hz in the right ear and in the left ear respectively. The percentage of males who 
obtained a threshold greater than 25dB decreased with each frequency. None of the 
participants obtained thresholds greater than 25dB at 4000HZ and 8000Hz. 
A one-tail t-test was conducted at each frequency for air conduction and bone 
conduction thresholds to determine if the difference between the average threshold 
obtained and the norm of 25dB was statistically significant. The null hypothesis being 
tested was, the males of the sample have normal hearing. The alternate hypothesis being 
that the males of the sample have impaired hearing. The p-value determined if the null 
hypothesis was rejected. At 250Hz in the right ear, a p-value of <0.0001 (air conduction) 
and 0.0005 (bone conduction) was obtained. This implies that the difference between the 
average of male participants in the study when compared to normal hearing thresholds 
was statistically significant at 250Hz for the right ear. The null hypothesis was therefore 
rejected at 250Hz. The differences were deemed not significant at all other frequencies in 
the right ear and all test frequencies in the left ear and the null hypothesis was, therefore, 
not rejected. While the difference between participants’ averages and the norm were 
deemed statistically insignificant, 38% of participants (n = 35) obtained a threshold 
greater than 25dB in the right ear and 23% (n = 21) in the left ear at 500Hz. The air 
conduction thresholds, bone conduction thresholds and t-test results for males are 
presented in Table 22.  
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4.3.2.2 Females 
The average at 250Hz for air conduction and bone conduction thresholds in the 
right ear was greater than 25dB. In the left ear, the air conduction and bone conduction 
thresholds were less than 25dB (Table 15). The difference in the average between air 
conduction and bone conduction ranged from 2.67dB to 6.41dB in the right ear and from 
1.17dB to 5.17dB in the left ear across all frequencies. The average of air conduction and 
air conduction thresholds decreased with each frequency. Sixty two percent of females    
(n = 20) showed an air conduction thresholds greater than 25dB at 250Hz in the right ear 
and 43% (n = 14) in the left ear. The difference between the right ear and the left ear 
increased for bone conduction thresholds with 59% (n = 19) obtaining thresholds greater 
than 25dB in the right ear compared to 40% (n = 13) in the left. The percentage of 
females who obtained a threshold greater than 25dB decreased with each frequency with 
none obtaining thresholds greater than 25dB at 4000HZ and 8000Hz. 
A one-tail t-test was conducted at each frequency for both air conduction and bone 
conduction thresholds to determine if the difference between the average threshold 
obtained and the norm of 25dB is statistically significant. At 250Hz, a p-value of 0.0004 
was obtained for air conduction thresholds in the right ear. This implies that the 
difference between the average of females, when compared to normal hearing thresholds, 
was statistically significant at 250Hz in the right ear for air conduction thresholds. The 
null hypothesis that female participants in the sample have normal hearing at 250Hz for 
air conduction thresholds was therefore rejected for the right ear. The differences were 
deemed not significant at all other frequencies in the right ear and all test frequencies in 
the left ear and the null hypothesis was, therefore, not rejected. While the difference 
between participants’ averages and the norm were deemed statistically insignificant, 38% 
of females (n = 5) obtained air conduction thresholds greater than 25dB at 500Hz in the 
right ear and 22% (n = 7) in the left ear. The air conduction thresholds, bone conduction 
thresholds and t-test results for females are presented in Table 23. 
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4.3.2.3 Males and Females 
Air conduction thresholds for males were higher than those of females at all test 
frequencies except 2000Hz in the left ear, and 4000Hz and 8000Hz bilaterally. Figures 10 
and 11 illustrate the difference in averages between males and females for air conduction 
testing for the right ear and the left ear respectively. 
Males vs Females : AC in Right Ear
0
5
10
15
20
25
30
35
40
250Hz 500Hz 1000Hz 2000Hz 4000Hz 8000Hz
Frequency
In
te
n
s
it
y
 (
d
B
H
L
)
Males
Female
 
Figure 10. The averages of males and females for air conduction testing for the right ear 
 
Males vs Females : AC in Left Ear
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Figure 11. The averages of males and females for air conduction testing for the left ear 
 
The percentage of males who obtained air conduction thresholds greater than 
25dB at 250Hz in the left ear was 18% more than that of females and 14% for bone 
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conduction thresholds. The difference in the average of males and females for air 
conduction thresholds ranged from 0.25dB to 1.92dB in right ear and from 1.02dB to 
3.67dB in the left. The difference in the average of males and females for bone 
conduction thresholds ranged from 0.21dB to 2.24dB in right ear and from 0.73dB to 
3.58dB in the left. Females obtained a greater average at 4000Hz bilaterally for both air 
conduction and bone conduction thresholds. 
A two-tailed t-test was conducted to compare the difference between males and 
females for air conduction and bone conduction thresholds. The null hypothesis was, 
there is no difference between males and females for air conduction and for bone 
conduction thresholds and the alternate hypothesis being there is a difference between 
males and females for air conduction and for bone conduction thresholds. A p-value of 
0.0083 was obtained for air conduction thresholds at 4000HZ in the left ear. The null 
hypothesis of thresholds for males and females being equal was rejected at 4000Hz for air 
conduction thresholds in the left ear. The difference between males and females for air 
conduction thresholds at 4000Hz was therefore statistically significant. The null 
hypothesis was not rejected for all other test frequencies for air conduction thresholds and 
all test frequencies for bone conduction thresholds bilaterally. Table 24 presents the 
results of the t-test for air conduction and bone conduction thresholds. 
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4.3.3  Diagnosis 
Of the 92 participants, 58 were diagnosed with coronary artery disease and 34 
with cardiomyopathy. Of the 58 participants diagnosed with coronary artery disease, 38 
were male and 29 female. Of the 34 participants diagnosed with cardiomyopathy, 22 were 
male and 12 female. Figure 12 provides the percentages of males and females who 
presented with each diagnosis. 
Sample split by Gender and Diagnosis
Males with 
CAD
41%
Females with 
CAD
22%
Males with CM
24%
Females with 
CM
13%
 
Figure 12. Percentage of males and females who presented with each diagnosis (coronary 
artery disease or cardiomyopathy). 
4.3.3.1 Coronary artery disease 
In participants with coronary artery disease, the average at 250Hz for air 
conduction thresholds was greater than 25dB bilaterally. The average for bone 
conduction thresholds were greater than 25dB in the right ear and less than 25dB in the 
left (Table 25). The difference in the average between air conduction and bone 
conduction ranged from 3.19dB to 6.03dB in the right ear and from 3.27dB to 5.17dB in 
the left ear. The average of air conduction and bone conduction thresholds decreased with 
each frequency. Fifty nine percent of participants (n = 34) obtained an air conduction 
threshold greater than 25dB at 250Hz in the right ear compared to 50% (n = 29) in the left 
ear. At 250Hz, the percentage of participants who obtained a bone conduction threshold 
greater than 25dB was 16% higher in the right ear compared to that of the left ear. The 
percentage of participants who obtained a threshold greater than 25dB decreased with 
each frequency with no participants obtaining thresholds greater than 25dB at 4000HZ 
and 8000Hz bilaterally. 
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A one-tail t-test was conducted to determine if the difference between the average 
threshold obtained and the norm of 25dB is statistically significant for participants with 
coronary artery disease. A t-test was conducted at each frequency for both air conduction 
and bone conduction thresholds. The null hypothesis being tested was, participants with 
coronary artery disease have normal hearing. The alternate hypothesis was that 
participants with coronary artery disease have impaired hearing. The p-value determined 
if the null hypothesis was accepted or rejected. 
At 250Hz, a p-value of <0.0001 was obtained for air conduction thresholds in the 
right ear. This implies that there is a statistically significant difference between the 
average air conduction thresholds of the sample, when compared to normal hearing 
thresholds, at 250Hz in the right ear. The null hypothesis that participants with coronary 
artery disease have normal hearing for air conduction thresholds was therefore rejected 
for 250Hz in the right ear. The differences were deemed not significant at all other 
frequencies in the right ear and all test frequencies in the left ear and the null hypothesis 
was therefore not rejected. While the difference between participants’ averages and the 
norm were deemed statistically insignificant, 33% of participants (n = 19) obtained 
thresholds greater than 25dB at 500Hz in the right ear and 23% (n = 13) in the left ear for 
air conduction thresholds. Thirty five percent of participants (n = 20) obtained thresholds 
greater than 25dB at 500Hz in the right ear and 13% (n = 7) in the left ear for bone 
conduction thresholds. Table 25 provides the results regarding air conduction thresholds, 
bone conduction thresholds and the t-test for participants with coronary artery disease. 
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4.3.3.2  Cardiomyopathy 
For participants with cardiomyopathy, the average air conduction and bone 
conduction thresholds at 250Hz was greater than 25dB bilaterally. The difference in the 
average between air conduction and bone conduction ranged from 3.38dB to 6.47dB in 
the right ear and from 3.82dB to 4.27dB in the left ear (Table 26). The difference in the 
average of air conduction and bone conduction thresholds decreased with each frequency. 
Of the 34 participants with cardiomyopathy, 71% (n = 24) obtained a threshold greater 
than 25dB at 250Hz in the right ear compared to 65% (n = 22) in the left ear for air 
conduction thresholds. At 250Hz, the percentage of participants who obtained a bone 
conduction threshold greater than 25dB was 12% higher in the right ear than in the left 
ear. The percentage participants who obtained a threshold greater than 25dB decreased 
with each frequency with none of the participants obtaining air conduction and bone 
conduction thresholds greater than 25dB at 4000HZ and 8000Hz bilaterally. 
A one-tail t-test was conducted to determine if the difference between the average 
threshold obtained and the norm of 25dB was statistically significant for participants with 
cardiomyopathy. A t-test was conducted at each frequency for both air conduction and 
bone conduction thresholds. The null hypothesis being tested was, participants with 
cardiomyopathy have normal hearing. The alternate hypothesis was that participants with 
cardiomyopathy have impaired hearing. 
At 250Hz, a p-value of <0.0001 was obtained for air conduction thresholds and a 
p-value of 0.0024 for BC thresholds in the right ear. This implies that the difference 
between the average of the sample, when compared to normal hearing thresholds, was 
statistically significant at 250Hz in the right ear for both air conduction and bone 
conduction thresholds. The null hypothesis that participants with cardiomyopathy have 
normal hearing at 250Hz was rejected for the right ear. The differences were deemed not 
significant at all other frequencies in the right ear and all test frequencies in the left ear 
and the null hypothesis was, therefore, not rejected. While the difference between 
participants’ averages and the norm were deemed statistically insignificant, 47% of 
participants (n = 16) obtained air conduction thresholds greater than 25dB at 500Hz in the 
right ear and 24% (n = 8) in the left ear. Thirty eight percent of participants (n = 13) 
obtained bone conduction thresholds greater than 25dB at 500HZ in the right ear and 9% 
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(n = 3) in the left ear. Furthermore, 59% of participants (n = 20) obtained a threshold 
greater than 25dB at 250Hz for bone conduction thresholds in the left ear. Table 26 
provides the results for air conduction thresholds, bone conduction thresholds and the t-
test for participants with cardiomyopathy. 
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4.3.3.3 Coronary artery disease and cardiomyopathy 
Air conduction and bone conduction thresholds for participants with coronary 
artery disease were higher than those with cardiomyopathy in the low frequencies 
bilaterally. The percentage of participants with cardiomyopathy who obtained air 
conduction thresholds greater than 25dB at 250Hz in the right ear was 12% higher than 
that of participants with coronary artery disease and 14% for bone conduction thresholds. 
In the left ear, the percentage of participants with cardiomyopathy who obtained air 
conduction thresholds greater than 25dB at 250Hz in the left ear was 15% higher than the 
percentage of participants with coronary artery disease and 14% for bone conduction 
thresholds. The percentage of participants who obtained thresholds greater than 25dB 
decreased with each frequency for air conduction and bone conduction thresholds 
bilaterally. 
Figures 13 and 14 illustrate the difference in averages between participants with 
coronary artery disease and participants with cardiomyopathy for air conduction testing 
for the right and the left ear respectively. 
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Figure 13. The averages of participants with coronary artery disease and participants with 
cardiomyopathy for air conduction testing for the right ear 
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CAD vs CM : AC in Left Ear
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Figure 14. The averages of participants with coronary artery disease and participants with 
cardiomyopathy for air conduction testing for the left ear 
 
A two-tailed t-test was conducted to compare the difference in air conduction and 
bone conduction thresholds between participants with coronary artery disease and 
cardiomyopathy. The null hypothesis was, there is no difference between the two 
diagnoses for air conduction and for bone conduction thresholds. The alternate hypothesis 
being there is a difference between the two diagnoses for air conduction and for bone 
conduction thresholds. Results from the two-tailed t-test revealed that the null hypothesis 
of no difference in thresholds for the two diagnoses being equal was not rejected for all 
test frequencies for air conduction thresholds and bone conduction thresholds. The results 
therefore indicate that there was not a significant difference between participants with 
coronary artery disease and participants with cardiomyopathy for all test frequencies. 
4.3.4  Duration of cardiovascular disease 
The average duration of cardiovascular disease (from date of diagnosis to date of 
testing) was two years and two months (range: 7 months to four years and one month; 
standard deviation: 0.95). The majority of participants who presented with duration of 
between one and two years were aged between 43 and 50 years. The majority of 
participants who presented with duration of between three and four years were aged 
between 49 and 54 years. Figure 15 illustrates the distribution of duration of 
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cardiovascular disease and the age of participants. Figure 16 illustrates the number of 
participants in groups with age rounded off to the nearest six months. 
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Figure 15. Distribution of participants according to duration of cardiovascular disease 
and age 
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Figure 16. The number of participants who presented within each duration group of 
cardiovascular disease (rounded off to the nearest six months) 
 
4.4 Analysis of Co-Variance for Independent Variables 
An analysis of co-variance was conducted at each test frequency for air 
conduction and bone conduction thresholds. The Type III SS (sum of squares) model of 
analysis was utilized. The Type III SS model is an appropriate measure as it assesses the 
effect of each factor and the interactions thereof on a specified entity (Roberts & Ilard, 
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2003). The model calculated an f-value. The lower the probability associated to the f-
value, the bigger the influence of the variable or combination. The analysis of co-variance 
also assessed the influence of the interaction of variables on pure tone thresholds. Results 
of the analysis of co-variance (f-values) for the variables and the interactions are 
presented in Table 27 for air conduction thresholds and in Table 28 for bone conduction 
thresholds. 
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The analysis of co-variance was conducted to determine the influence of each 
variable on hearing thresholds and to determine the effect of the 
combinations/interactions of variables on hearing thresholds. The following results were 
obtained: 
4.4.1  Age 
An analysis of co-variance was conducted at each test frequency for air 
conduction thresholds (Table 27) and bone conduction thresholds (Table 28). The f-value 
for age ranged from 0.0260 to 0.9338 indicating that age (individually and in 
combination with all quantifiable variables) did significantly impact hearing thresholds at 
all test frequencies for air conduction and bone conduction thresholds. 
4.4.2   Gender 
An analysis of co-variance was conducted at each test frequency for air 
conduction thresholds (Table 27) and bone conduction thresholds (Table 28). In the left 
ear, an f-value of 0.0149 was obtained for air conduction thresholds at 4000Hz and 
0.0076 for bone conduction thresholds at 4000Hz. These values indicated that gender, as 
an individual variable, had a significant influence on air conduction and bone conduction 
thresholds at 4000Hz in the left ear. It was found that gender, when assessed with various 
combinations of the quantifiable variables in the study, did not influence hearing 
thresholds at all test frequencies.  
A Bonferroni correction was also conducted to determine the probability of the 
significance of gender on hearing thresholds. The Bonferroni correction (α=0.01) was 
conducted at all test frequencies for air and bone conduction thresholds bilaterally. There 
was a statistically significant difference at 4000Hz in the left ear. Table 29 provides the 
result of the Bonferroni correction at 4000Hz in the left ear. 
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Table 29 
 
The Analysis of the Difference between Males and Females at 4000Hz in the Left Ear for 
Air Conduction and Bone Conduction Thresholds 
 
 
Categories Difference 
Standardized 
difference 
Critical 
value 
Pr.> 
Diff 
AC 2 ~ 1 3.667 2.746 2.637 0.007* 
BC 2 ~ 1 3.573 2.656 2.637 0.009* 
Note. *=significant at confidence level of 99%; AC=air conduction; BC=bone conduction; 2=gender; 
1=hearing thresholds 
 
The Bonferroni correction also concluded that gender significantly influenced air 
conduction and bone conduction thresholds at 4000Hz in the left ear. 
4.4.3  Diagnosis 
In order to determine the influence of diagnosis on air conduction and bone 
conduction thresholds, an analysis of co-variance was conducted at each test frequency 
for air conduction thresholds (Tables 27 and 28). The f-value for diagnosis ranged from 
0.4314 to 0.9812 indicating that diagnosis, individually and in combination with all 
quantifiable variables, did not significantly impact on air conduction and bone conduction 
thresholds across the frequency range. 
4.4.4  Duration of cardiovascular disease 
In order to determine the influence of the duration of cardiovascular disease on air 
conduction and bone conduction thresholds, an analysis of co-variance was conducted at 
each test frequency. In the right ear, statistically significant results were obtained for air 
conduction thresholds at 250Hz, 500Hz, 1000Hz, 2000Hz and 4000Hz. In the left ear, 
statistically significant results were obtained for air conduction thresholds at 250Hz, 
500Hz, 1000Hz and 2000Hz. The f -value was also significant for bone conduction 
thresholds at 250Hz, 500Hz, 1000Hz and 2000Hz bilaterally. This indicated that duration 
of cardiovascular disease, as an individual variable, had significant influence on hearing 
thresholds at the aforementioned frequencies bilaterally. Duration of cardiovascular 
disease, when assessed with various combinations of the quantifiable variables, did not 
influence hearing thresholds at all test frequencies. 
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4.4.5  Interaction of independent variables 
The analysis of co-variance assessed the influence of the combinations of 
variables at each test frequency for air conduction thresholds and for bone conduction 
thresholds (Tables 27 and 28). The results from the analysis of co-variance concluded 
that there were no interactions which significantly influenced hearing thresholds at all test 
frequencies. 
4.5  Conclusion 
This chapter highlighted the results of the study and were organized, analysed and 
described in relation to the aims of the study. The results revealed outer ear pathologies 
and middle ear pathologies to have minimal influence on hearing thresholds in 
individuals with cardiovascular disease. A low frequency, sensorineural hearing loss was 
prominent in participants who presented with elevated pure tone thresholds. This was 
further confirmed by distortion product otoacoustic emissions  
Age and diagnosis, as independent variables, were found to have minimal 
influence on pure tone thresholds and no significant difference was noted in its 
interaction with other variables. Conversely, gender was found to significantly influence 
air conduction and bone conduction thresholds at 4000Hz in the left ear. These results 
indicate that, whilst gender may not influence hearing thresholds in the right ear, there 
were significant differences between the results for males and females at 4000Hz in the 
left ear. 
Most importantly, duration of cardiovascular disease (as an individual variable) 
was found to influence pure tone thresholds in this sample. 
Based on the results, the prevalence of a bilateral hearing loss was five percent. 
The prevalence of hearing loss was 11% in the right ear and five percent in the left ear, 
indicating the prevalence of hearing loss to be higher in the right ear than in the left. 
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CHAPTER 5 
 
DISCUSSION OF RESULTS 
 
This chapter provides a summary of the findings of the study and the influence of the 
independent variables. It also includes a discussion of these results in relation to the 
literature. Data is interpreted so that conclusions can be drawn on the prevalence of 
hearing loss in individuals with coronary artery disease and cardiomyopathy.  
5.1. Summary of Audiological Findings 
Results revealed that 48% of the participants in the study reported experiencing 
hearing difficulties. Of those participants, 89% presented with increased thresholds in at 
least one frequency in at least one ear. This high correlation suggests fairly accurate self-
reported of hearing difficulty experienced.  
These findings are supported by the literature (Nondhal, 1998; Sindhusake et al., 
2001; Voeks, Gallagher, Langer, & Drinka, 1993). In a study conducted by Nandhal 
(1998), the percentage of self-reported and of actual assessed hearing loss was within 
three percent thus indicating accuracy in self-reported hearing loss. Similarly, Sindhusake 
et al. (2001) reported an 11% difference between self-reported hearing loss and a hearing 
loss confirmed by pure tone audiometry. A slightly higher difference of 15% was 
reported by Voeks et al. (1993). Interestingly, Gomes, Hwang, Sobotova and Stark 
(2001) found variable degrees of agreement between self-reported hearing loss and 
audiometric hearing loss. Agreement ranged from 27% to 88% depending on the 
frequency range being tested. These findings support the inclusion of questions regarding 
perceived hearing difficulties in screening programs as it would be beneficial in 
identifying adults with cardiovascular disease who may present with a hearing loss. 
The majority of participants in the current study did not present with any 
abnormalities during the otoscopic examination that would impact on hearing thresholds. 
This confirms the findings of a study that investigated the prevalence of hearing loss in 
elderly individuals with cardiovascular disease. In that study, less than one percent of 
participants failed the otoscopic examination in one or both ears (Pratt et al., 2009). 
Similarly, Torre et al. (2005) found 1% (n = 5) of their participants presented with 
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cerumen. It can therefore be postulated that outer ear pathologies do not have a 
significant influence on hearing thresholds in adults with cardiovascular disease. 
More than 95% of participants in the current study presented with type A 
tympanograms bilaterally indicating normal middle ear functioning. It can therefore be 
postulated that middle ear pathology only contributed minimally to hearing loss in adults 
with coronary artery disease and cardiomyopathy. A study conducted in the United States 
of America also revealed a low prevalence of abnormal middle ear function, as only eight 
percent of those participants presented with some form of conductive involvement 
(Cruickshanks et al., 1998). 
Acoustic reflexes thresholds are affected by degree of hearing loss (Gelfand, 
Schwander, & Silman, 1990). Gelfand et al. (1990) found that acoustic reflex thresholds 
are the same for individuals with normal hearing and those with sensorineural hearing 
loss with pure tone thresholds are less than 50dB HL. A typical pattern associated with 
cochlear hearing loss includes type A tympanograms and normal reflex thresholds 
(providing air conduction thresholds do not exceed 50dB HL) (Gulya, Minor, & Poe, 
2010) 
Ninety two percent of participants in the current study presented with pure tone 
thresholds less than 50dB HL. Interestingly, twenty one of those participants obtained 
elevated acoustic reflex thresholds. These results, therefore, indicate that the majority of 
participants with thresholds between 25dB HL and 50dB HL presented with a cochlear 
pathology. 
The results from pure tone testing revealed that 89% (n = 81) of the participants 
presented with hearing within normal limits bilaterally based on pure tone averages (pure 
tone average<25dB). However, only 66% (n = 61) of these participants presented with all 
thresholds across all frequencies less than 25dB. Of the participants who presented with a 
hearing loss, 98% (n = 31) presented with a low frequency sensorineural hearing loss. 
These findings are supported by the results of the speech audiometry measures 
conducted. In the current study, a speech reception threshold-pure tone average 
difference of less than 5dB was obtained, indicating reliable results.  
Of the participants who presented with a hearing loss, speech discrimination 
testing confirmed the cochlear nature of the hearing loss in the 96% of those participants. 
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All participants’ performance improved as the intensity was increased, with the majority 
obtaining between 90% and 100%, indicating normal ability to detect words (Kaplan et 
al., 1993). Individuals with cochlear pathology present with no decline or less than 20% 
decline as intensity increases (Roeser et al., 2000). The results of the current study, 
therefore, indicate that participants present with a hearing loss which is cochlear in 
nature. 
Distortion product otoacoustic emissions, an electrophysiological measure, 
revealed that the otoacoustic emissions’ strength increased with each increase in 
frequency bilaterally. This indicates that otoacoustic emissions were weakest in the lower 
frequencies. This corresponds with the pure-tone thresholds obtained in the current study 
that also revealed a hearing loss in the low frequencies for some participants. As 
distortion product otoacoustic emissions provide frequency specific information based on 
discrete frequency stimuli, they are often compared to audiometric configurations. In 
individuals with sensorineural hearing loss, distortion product otoacoustic emissions are 
often reduced or eliminated only for the stimulus-frequency regions which coincide with 
the impaired region (Gaskill & Brown, 1990; Stover, Gorga, Neely, & Montoya, 1996).  
It is postulated that impairment in blood flow to the cochlea as a result of changes 
in blood pressure, blood flow and oxygen-carrying capacity may alter hearing (Lassman 
& Aldridge, 1985). This impairment will ultimately result in a sensorineural hearing loss 
(Nakashima et al., 2003). The capillary network at the base of the cochlea is greater than 
at the apex, where the outer hair cells which are sensitive to low frequency sounds are 
situated. The hypothesis is therefore that blood flow to the apex may be compromised in 
these participants with cardiovascular disease. Further research is however required to 
determine the impact of cardiovascular disease on the blood flow to the cochlea and the 
chemical changes in the organ of Corti. 
Previous studies investigating cardiovascular disease and hearing impairment 
have reported conflicting results. Some studies found a low frequency hearing loss to be 
more prevalent in individuals with the disease (Friedland et al., 2009; Gates et al., 1993). 
Gates et al. (1993) conducted a study (n = 1662) on the geriatric population and included 
participants with either coronary artery disease, intermittent claudication (a clinical 
feature of individuals with peripheral arterial disease (Abela, 2004)) or exposure to 
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cardiovascular disease risk factors. The results revealed that participants presented with a 
low frequency sensorineural hearing loss. They postulated that the low frequency hearing 
loss may be associated with microvascular disease leading to atrophy of the stria 
vascularis. Friedland et al. (2009) investigated a possible link between audiometric 
measures and underlying cardiovascular disease in the geriatric population. The study 
(n=1168) found a strong correlation between low frequency hearing loss, cardiovascular 
disease and risk factors. The results also revealed a significant association between 
hearing loss and the following types of cardiovascular disease: peripheral vascular 
disease, coronary artery disease and myocardial infarction.  
Conversely, another study concluded that 55% of elderly individuals with 
cardiovascular disease between the ages of 72 years and 96 years (n = 548) presented 
with a high frequency hearing loss with normal hearing thresholds in the low frequencies 
(Pratt et al, 2009). These participants presented with an array of cardiovascular diagnoses 
(for example, myocardial infarction, angina pectoris, atrial fibrillation) and exposure to 
risk factors such as smoking and increased stress. The study also concluded that the 
prevalence of hearing loss in adults with cardiovascular disease increased with age. In 
addition, individuals exposed to risk factors known to cause hearing loss were also 
included in the study (for example, exposure to noise, treatment for cancer and ingesting 
ototoxic medication).  
Similar findings were reported in a study by Torre et al. (2005) conducted on 
older adults (43 years to 84 years) with a range of diagnoses (angina, myocardial 
infarction and stroke). Torre et al. (2005) found normal thresholds in the low frequencies 
with 55% of female and 70% of male participants presenting with a high frequency 
sensorineural hearing loss. 
5.2 Independent Variables 
The four independent variables in this study were (i) age, (ii) gender, (iii) 
diagnosis, and (iv) the duration of cardiovascular disease. 
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5.2.1  Age 
As no statistically significant results were obtained, age did not impact on hearing 
thresholds of participants with coronary artery disease and cardiomyopathy in this study. 
There is an abundance of literature which reported hearing thresholds to be worse as age 
increases (Pratt et al., 2009; Cruickshanks, 1998; Agrawal Platz, & Niparko, 2008; 
Wallhagen, Strawbridge, Cohen, & Kaplan, 1997; Zhan, Cruickshanks, Klein, et al., 
2009). Similarly, an increase in the prevalence of hearing loss in adults with 
cardiovascular disease reportedly increased with age (Pratt et al., 2009). The prevalence 
rate increased from 42% (in the 7th decade of life) to 71% in the 8th decade of life. It is 
important to note that this study included the geriatric population and the effect of 
presbycusis must, therefore, be taken into account.  
5.2.2  Gender 
The results revealed that gender only had a significant influence on pure tone air 
conduction thresholds at 4000Hz in the left ear; however test results did not indicate 
whether it was males or females who were more affected at that frequency.  
Whilst gender did not influence pure tone thresholds at most frequencies in this 
study, previous studies have found a significant difference between males and females 
(Torre et al., 2005; Pratt et al., 2009; Wallhagen et al., 1997; Zhan et al., 2009; Wiley et 
al., 2001). Females were found to present with lower thresholds and pure tone averages 
when compared to males (Torre et al., 2005; Pratt et al., 2009; Wallhagen et al., 1997; 
Zhan et al., 2009; Wiley et al., 2001). Torre et al. (2005) utilized distortion product 
otoacoustic emissions in addition to pure tone audiometry and reported that males have 
reduced emission strength when compared to that of females. This was attributed to 
increased noise exposure in males. Other possible causes for the differences in males and 
females include differences in stress levels, lifestyle, diet and exposure to more risk 
factors known to cause hearing loss (for example, smoking, hypertension) (Wiley et al., 
2001; Pratt et al., 2009; Torre et al., 2005). Whilst the literature indicates that males may 
present with more severe hearing impairments when compared to females, both males 
and females with a history of cardiovascular disease are equally likely to present with a 
low frequency hearing loss (Gates et al., 1993). 
  
111
The aforementioned studies provide general results across the frequency range; 
however, none provide insight regarding possible gender differences regarding 
audiometric results at 4000Hz. Although Torre et al. (2005) found the distortion product 
otoacoustic emissions in males with cardiovascular disease to be weakest at 4000Hz, the 
results were determined utilizing only the combined average of emissions of the right ear 
and the left ear and no ear specific information was provided. As no significant difference 
was found at 4000Hz for distortion product otoacoustic emissions in the current study, 
this statistically significant result needs to be interpreted with caution. 
5.2.3  Diagnosis 
Results revealed no significant influence of diagnosis (individually and in 
combination with other independent variables) on hearing thresholds. These results 
indicated that participants with cardiovascular disease, irrespective of a diagnosis of 
coronary artery disease or cardiomyopathy, presented with significantly elevated 
thresholds at 250Hz in the right ear. Previous studies investigating hearing loss in 
individuals with different types of cardiovascular disease have reported prevalence rates, 
ranging from 6% to 20%. However, no significant differences in diagnoses have been 
reported. 
 In a study conducted on the geriatric population diagnosed with myocardial 
infarction, Gates et al. (1993) found no influence on hearing in females. However males 
with a history of coronary artery disease or heart attack were twice as likely to present 
with a low frequency hearing loss. 
5.2.4  Duration of cardiovascular disease 
The most significant finding was that the duration of cardiovascular disease 
significantly influenced all air conduction thresholds in the right ear, and 250Hz, 500Hz, 
1000Hz and 2000Hz in the left ear. Similarly, duration significantly influenced bone 
conduction thresholds at 250Hz, 1000Hz and 2000Hz bilaterally. The correlation co-
efficient (r = 0.486) between duration of cardiovascular disease and age indicated that the 
combination of duration of the disease and age may influence hearing thresholds.  
Although previous studies investigating cardiovascular disease and hearing loss 
have all described participants as having a history of cardiovascular disease, none 
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provided detail regarding the duration, age of onset and severity of disorder (Torre et al., 
2005; Pratt et al., 2009; Gates et al., 1993). 
From the audiological findings and the results from the independent variables, it is 
evident that the area of cardiovascular disease and hearing loss comprises many aspects. 
However, understanding all the facets of this topic would not be possible without 
understanding the prevalence of hearing loss in this population. 
5.3 Prevalence of Hearing Loss in Cardiovascular Disease 
The prevalence of hearing loss (based on a pure tone average greater than 25dB 
bilaterally) in this study was 5%. The prevalence of hearing loss was 11% in the right ear 
and 5% in the left. In the right ear, a mild hearing loss was found in 5% of the sample and 
a moderate hearing loss was found in 6% of the sample. All participants who presented 
with an elevated pure tone average in the left ear presented with a mild hearing loss. 
Many studies have provided tentative results regarding the prevalence rate of hearing loss 
in the general population (including various age groups). 
In the United States of America, the prevalence of hearing loss in the general 
population between 40 and 49 years of age is reported as 6% (Agrawal et al., 2008). The 
prevalence increased to 15% in individuals between the ages of 50 and 59 years. 
Similarly, Australia appeared to have a prevalence of a mild hearing loss in 5% of 
individuals between the ages of 15 to 50 (Hogan, O’Loughlin, Miller, & Kendig, 2009). 
The prevalence increased to 28% (mild hearing loss) in individuals between the ages of 
51 and 60 years, and to 12% in individuals with a moderate hearing loss. Similar 
estimates were found in Great Britain (Hogan et al., 2009). The results of the current 
study are similar to the findings of the previous studies. 
 The prevalence of hearing loss in developing countries has not been extensively 
researched and is not as well documented as that of developed countries. The reported 
prevalence rates in India, Thailand, Bangkok and Brazil are similar to that found in the 
current study. Whilst no statistics are available regarding the adult population in South 
Africa, the percentage of participants who presented with a hearing loss in the current 
study is similar to the prevalence of the aforementioned African countries such as Nigeria 
(Mathers et al., 2000; Lasisi et al., 2010). These statistics indicate that the prevalence of 
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hearing loss in the current study (regarding cardiovascular disease) is congruent with that 
expected in other countries. 
Whilst the prevalence reported in these studies are similar to the prevalence of 
hearing loss in adults with cardiovascular disease, previous studies reported a high 
frequency hearing loss as opposed to the low frequency hearing loss found in the current 
study. The nature of the hearing loss is, therefore, contradictory. 
The prevalence of hearing loss in individuals with cardiovascular disease has not 
been extensively researched; however, the few studies which have been conducted have 
made tentative suggestions regarding the prevalence in specific populations with this 
disease. Research indicates that the prevalence of hearing loss in adults with any form of 
cardiovascular disease range from six percent to as high as 50%. The prevalence of 
unilateral hearing loss in individuals with vertebro-basilar insufficiency is reported as 
20% (Yamasoba, 2001). Another study reported a prevalence of approximately 50% 
percent in a geriatric population with the disease (Pratt et al., 2009). The prevalence of 
hearing loss in older adults with myocardial infarction ranged from six percent to 13% 
(Torre et al., 2005). It was also reported that for older adults with angina, the prevalence 
is between seven percent and 10% (Torre et al., 2005).  
The aforementioned percentages do not greatly differ from the studies conducted 
on the general population in both developed countries and developing countries; they are, 
however, slightly higher than those found in the current study. This indicates that the 
prevalence of hearing loss in adults with cardiovascular disease is not significantly higher 
than the prevalence of hearing loss in the general population. 
5.4 Conclusion 
 This chapter highlighted the results of the research. The audiological evaluation 
revealed a low frequency, sensorineural hearing loss with the right ear being worst 
effected. Results from acoustic reflexes, pure tone thresholds and distortion product 
otoacoustic emissions indicate a cochlear site of lesion. 
 The prevalence of hearing loss in the current study appeared to be similar to that of 
the general population. When compared to the prevalence rates of hearing loss in 
disorders known to cause hearing impairment, the prevalence rate of the current study 
was significantly lower. 
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 The results of the current study supported the findings of previous studies regarding 
the influence of gender on hearing thresholds. Whilst the duration of cardiovascular 
disease influenced pure tone thresholds in this study, previous literature does not support 
these findings. 
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CHAPTER 6 
 
CONCLUSION 
 
6.1 Introduction 
This study investigated the prevalence of hearing loss in adults with 
cardiovascular disease, described the audiological findings of the participants and 
determined which variables influence pure tone thresholds. This chapter summarizes the 
findings of the study. Thereafter, it focuses on the strengths and limitations of the study, 
the recommendations for future research and the implications of the results in a clinical 
setting. 
6.2 Summary of Results 
The results of this study have provided insight regarding the prevalence of hearing 
loss in adults aged between 45 and 54 years with coronary artery disease and 
cardiomyopathy. 
Thirty four percent of participants with cardiovascular disease in the current study 
presented with thresholds greater than 25dB at 250Hz bilaterally indicating low 
frequency involvement. This was confirmed by distortion product otoacoustic emission 
results, indicating the apex of the cochlea to be a possible site of lesion. Of the four 
independent variables studied, the age of participants and their diagnosis did not 
influence pure tone thresholds. Gender, as an individual variable, influenced air 
conduction pure tone thresholds at 4000Hz in the left ear; however, in combination with 
other variables, gender influenced pure tone thresholds marginally. Duration of 
cardiovascular disease significantly influenced pure tone thresholds in the low and mid 
frequencies bilaterally. 
6.3 Strengths of the Study 
• This study has utilized a quantitative, descriptive, survey research design which 
ensured that the results were objective, accurate and reliable. As the researcher 
did not know any of the participants, researcher bias was minimized, enhancing 
the reliability of results. A reliability co-efficient was calculated and a score of 
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92% was obtained this indicating good inter-rater reliability. Reliability was 
further enhanced by applying the cross-check principle to compare the speech 
reception threshold and pure tone average results. 
• A comprehensive test battery was utilized to evaluate participants, thereby 
ensuring that different components of the auditory pathway were assessed. This 
allowed for the identification of a possible site of lesion. 
• A large sample size was utilized thus allowing for some degree of generalization 
of results to the general population of individuals diagnosed with cardiovascular 
disease. 
• Stringent inclusion/exclusion criteria allowed for the exclusion of extraneous 
variables (for example, noise exposure, ototoxicity, and diabetes mellitus) which 
may influence hearing thresholds. This ensured that results were valid and hearing 
thresholds could, therefore, be more likely attributed to the influence of 
cardiovascular disease. 
• This study excluded individuals below 40 years of age and above 55 years of age. 
This allowed for the exclusion of presbycusis which may have influenced hearing 
thresholds. 
6.4 Limitations 
Whilst this study has provided valuable information regarding the audiological 
presentation of individuals with cardiovascular disease, the limitations of this study need 
to be taken into account: 
• As this study included only individuals diagnosed with coronary artery disease or 
cardiomyopathy, results of this sample may therefore not be representative of the 
general population and consequently results cannot be generalized to all 
individuals with cardiovascular disease. 
• Because this study excluded individuals below 40 years of age and above 55 years 
of age, the results may not be representative of the general adult population. 
Results should be interpreted with caution, as they cannot be generalized to all 
adults with cardiovascular disease. 
• This study comprised of 92 participants. This sample size is not representative of 
the general population and results cannot be generalized.  
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• Whilst a comprehensive test battery was utilized to assess participants, contra-
lateral acoustic reflexes were not included in the test battery. Distortion product 
otoacoustic emissions below 750Hz were another significant component which 
was omitted due limited accessibility to equipment. Distortion product otoacoustic 
emissions below 750Hz would have provided valuable low frequency data. The 
exclusion of the two aforementioned tests resulted in a limitation of analysis of 
results however; as a comprehensive test battery was utilized, assessment of the 
various elements of the auditory pathway was still possible. 
• Furthermore, distortion product otoacoustic emission results in the low 
frequencies should be interpreted with caution as the influence of environmental 
noise needs to be considered (Hall, 2000). 
• The research design of this study was a survey research design. As a result, it did 
not allow for analysis regarding possible hearing loss prior to diagnosis of 
cardiovascular disease. Furthermore, it did not enable analysis regarding 
progression of hearing loss over time.  
• The maximum duration of cardiovascular disease of participants in this study was 
four years. Since the duration of cardiovascular disease was found to significantly 
influence hearing thresholds in this study, the maximum duration of four years 
limited the analysis of the interaction between duration of the disease and hearing 
thresholds. 
6.5 Implications 
Individuals living with hearing loss experience many emotional and social challenges. 
Similarly, individuals with cardiovascular disease experience many of the same 
challenges; however, living with this disease brings its own physical and mental 
challenges. When faced with an individual presenting with both a cardiovascular disease 
and a hearing loss, it is imperative that the medical team is aware of these challenges. 
Referral to the appropriate professionals (for example, a psychologist, or an audiologist) 
for further assessment, and management is therefore essential. 
 The information from this study may encourage the inclusion of audiologists in the 
multi-disciplinary cardiovascular disease team to manage the audiological complaints of 
patients with cardiovascular disease. 
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More specifically, the results of this study serve to increase the audiologist’s 
knowledge regarding the presentation of hearing loss in adults with coronary artery 
disease and cardiomyopathy. 
 It is well known that prevention and early identification of a disease are key elements 
in any medical profession (Foody, 2001). This highlights the need for the implementation 
of early identification programmes, targeting individuals with cardiovascular disease that 
include hearing screening and information sessions for medical personnel working in 
cardiology departments. 
6.6 Recommendations for Future Research 
The results revealed a variety of interesting trends. Preliminary answers and many 
more questions were raised that will need to be answered in the following type of future 
research: 
• The replication of this study on individuals that present with other types of 
cardiovascular disease would expand the research in the field of hearing loss and 
this disease. 
• This study can be replicated, following individuals with cardiovascular disease 
longitudinally from the time of diagnosis in a prospective study. This will provide 
valuable information regarding the interaction between the two variables and the 
predictive model in calculating possible hearing loss. It would further allow for 
the investigation of the progression of hearing loss in individuals with 
cardiovascular disease over time.  
• The influence of duration of cardiovascular disease requires further investigation 
as the maximum duration for the current study was four years and duration of this 
disease was found to influence hearing thresholds. 
• Future studies should also expand on the audiological test battery used in the 
current study to include contra-lateral acoustic reflexes and low frequency 
distortion product otoacoustic emissions. 
• The difference in results between the right ear and the left ear requires further 
investigation as this was a pattern identified in the results of several tests. 
  
119
• The replication of this study in other South African populations will contribute 
valuable information in understanding the audiological presentation in adults with 
cardiovascular disease in South Africa. 
6.7. Conclusion 
This chapter summarized the rationale and the results of the research as described 
in Chapter 4. By means of a critical evaluation of the research, combined with a 
discussion of the study’s strengths and weaknesses, the validity of the study is established 
and the clinical implications of the research were pointed out. 
Given the dearth of information on cardiovascular disease and its influence on 
hearing thresholds, the groundwork has been laid for future, more in-depth research to 
replicate, refine, and expand the current study in various ways that could be generalized 
beyond the specific population who participated in this study. 
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Appendix A: Questionnaire for participants (case history interview) 
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Questionnaire for Participants: 
(to be completed by researcher based on participant’s verbal/Sign Language input) 
 
Participant Number: ______________________  
Date of Completion: _____________________Date of Birth: ______________________ 
Age: _________________________________ Gender: Male / Female (please circle) 
 
Section A: Hearing: 
1. Do you have hearing difficulties? Yes No 
2. If yes, please describe the nature of 
your hearing difficulty (e.g. difficulty 
hearing in noise, environmental 
sounds are too soft) 
  
3.  If you have hearing problems, which 
ear is it difficult for you to hear? 
Right  Left Both 
4. If you have hearing difficulties, how 
many months/years has it been since 
you noticed the problem? 
 
5. Has your hearing changed since you 
have been diagnosed with a heart 
condition? 
Yes No 
6. If yes, please explain how it has 
changed (e.g. has it gotten worse?) 
 
 
Section B: Heart: 
1. Do you have heart problems? Yes  No 
2. If you have heart problems, when 
was the problem first noticed? 
 
3. What is your medical diagnosis?  
4. What medication are you currently 
taking for your heart problems? 
 
5. Do you have Hypertension (high 
blood pressure)? 
Yes No 
6. A) If yes, what medication are you 
currently taking? 
 
B) For how many months/years have 
you been taking hypertensive 
medication? 
 
C) Does your blood pressure 
fluctuate? 
Yes No 
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Section C: General 
(Please circle and provide details where necessary) 
 
Do you have any of the following? 
 
1. A ringing/buzzing sound in the ear/s? Yes / No 
If yes, please answer the following: 
A. Which ear is it in? ______________________ 
B. Is it there all the time or only sometimes? __________________________ 
C. Which time of the day/night is it worse? ___________________________ 
D. Is the sound a sharp ringing (e.g. like a bee buzzing/telephone ringing) or 
a booming sound? 
______________________________________________ 
 
2. Dizziness or feeling off balanced? Yes / No 
If yes, please answer the following: 
A. When do you get dizzy (e.g. with quick movements, whilst walking)? 
________________________________________ 
B. How often to you get a dizzy spell (e.g. daily/once a week/once a 
month/with all sudden movements)? ______________________________ 
C. Do you get dizzy only when your blood pressure is high? _____________ 
 
3. Have you been exposed to excessive or very loud noise (e.g. working in a 
factory with machines or hearing the sound of a gunshot)? 
__________________________________________________________________ 
If yes, please answer the following: 
A. What is the nature of the sounds you have been exposed to (e.g. 
machines)? __________________________________________________ 
B. For how many months/years have you been exposed to loud sounds? 
____________________________________________________________ 
C. Have you used earmuff or any form of ear protection when exposed to 
loud sounds? _________________________________________________ 
 
4. Do you have diabetes? Yes / No 
 
5. Do you have kidney problems? Yes / No 
 
6. Do you have cancer? Yes / No 
If yes, please answer the following: 
A. Have you been for chemotherapy? _______________________________ 
B. Have you been for radiation therapy? _____________________________ 
C. Have you experienced pain in your ears since the cancer? _____________ 
D. What changes have you noticed in your hearing since your diagnosis and 
treatment? ___________________________________________________ 
E. Does your hearing fluctuate from day-to-day? ______________________ 
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F. Do you notice a difference in hearing in one ear compared to the other 
ear? ________________________________________________________ 
 
 
7. Do you currently smoke? Yes / No 
A. If yes, how many cigarettes do you smoke a day? 
____________________________________________________________ 
B. How many months/years have you been smoking for? 
____________________________________________________________ 
 
8. Have you had surgery/an operation around the head/neck region? Yes / No 
If yes, please answer the following: 
A. What was the reason for the surgery? _____________________________ 
B. What was the procedure called? _________________________________ 
C. What was the outcome of the surgery? ____________________________ 
D. Did you notice any hearing difficulties after the surgery? ______________ 
 
9. Have you had an injury around the head/neck region? Yes / No 
If yes, please answer the following: 
A. What was the nature of the trauma? _______________________________ 
B. Did you notice any hearing difficulties after the trauma? ______________ 
 
10. Does anyone in your family have a hearing loss? Yes / No 
If yes, please answer the following: 
A. How are you related to them? ___________________________________ 
B. At what age did they begin having hearing difficulties? 
____________________________________________________________ 
C. Was the hearing loss due to a medical condition? If so please provide 
details ______________________________________________________ 
 
11. Are you taking any medication for other health reasons? Yes / No 
If yes, please answer the following: 
A. What is the name/s of the medication? ____________________________ 
B. What is the reason for taking this medication? ______________________ 
C. Has your hearing changed since you began taking this medication? If yes, 
how has it changed (e.g. has it gotten worse?)? ______________________ 
 
 
Section D: To be completed by the researcher 
(Information to be obtained from participants’ medical records) 
 
1. Diagnosis and aetiology: 
__________________________________________________________________ 
__________________________________________________________________ 
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2. Date of diagnosis/length of CVD: 
____________________________________________  
 
 
3. Treatment received (nature of intervention/length/operation or procedures/ 
hospitalization/strategies/lifestyle modifications): 
__________________________________________________________________
________________________________________________________________ 
 
 
4. Medication (name and function, dosage and schedule, onset, changes in 
medication): 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
5. Symptoms: 
__________________________________________________________________ 
 
6. Time of onset of symptoms: 
__________________________________________________________________ 
 
7.  Changes in symptoms: 
__________________________________________________________________  
 
8. Other medical history (e.g. visual difficulties, asthma, etc): 
__________________________________________________________________
__________________________________________________________________ 
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Appendix B: Participant information sheet and informed consent form 
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SPEECH PATHOLOGY AND AUDIOLOGY 
School of Human & Community Development 
Faculty of Humanities 
University of the Witwatersrand 
Private Bag 3, WITS, 2050 
Tel: (011) 717 4565 Fax: (011) 717 4572 
 
Participant Informed Consent Form 
 
Good Day. 
 
My name is Trusha Solanki and I am currently completing a Masters degree in Audiology 
at the University of Witwatersrand. As a requirement of the course, I will be completing a 
research project on the topic of cardiovascular disease and hearing loss. 
 
This study aims to investigate the impact of cardiovascular disease on hearing. The 
results will be important for audiologists in terms of playing a more active role in the 
management of individuals with cardiovascular disease. 
 
I hereby invite you to participate in this study. Should you agree to be a participant in this 
study, you would be requested to complete a case history form and undergo a hearing test 
at South Rand Hospital. This process will take approximately 40-50 minutes. You would 
have to travel to South Rand Hospital on the day of your hearing test. If you do not have 
a means of transport but would still like to participate in the study, please inform the 
researcher and transport arrangements can be made. If you are able to travel to the 
hospital using your own transport, you will be offered R50.00 financial compensation for 
your travelling expenses on the day of the hearing test.  
 
Your participation is voluntary and all the information you provide will be anonymous 
and confidential. There will be no identifying information on the case history form and 
the assessment forms and all personal information will be viewed only by the researcher. 
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If you decide to participate and then withdraw from the study, there will be no penalty or 
negative consequences. Refusal to participate will involve no penalty/loss of benefits. 
 
There is no direct benefit from participating in this study however you will get 
information regarding the status of your hearing. The information from this study will be 
valuable in the assessment of individuals with cardiovascular disease. There are no 
known risks associated with your participation in this research. 
 
Should you wish to know the results of your hearing test, please inform the researcher 
and the results will be discussed on the day of the hearing test. The results of your 
hearing test may or may not indicate a hearing loss. If a hearing loss is detected, it may 
impact on your quality of life, your communication and your emotional well-being. A 
counsellor will, therefore, be available if you would like to discuss your hearing loss 
further. An audiologist will also be available to discuss ‘the way forward’ regarding your 
hearing loss. You may also request a report of your results which will then be posted to 
you. Any recommendations which are made will be based on the results of your 
individual hearing test. You are not obligated to follow through with the 
recommendations. You may also request that the results of your hearing test are not 
discussed with you. 
 
Your medical and previous audiological records (if applicable) will help in getting a 
diagnosis and an in-depth medical history. I would, therefore, appreciate your consent to 
access your medical and audiological results. 
 
Should you wish to participate in this study, please complete and sign the informed 
consent form below. 
Should you need further information or have any queries about this study, don’t hesitate 
to contact me on 083 455 7770 / (011) 888-9655 or email at tsolanki9@gmail.com. 
Alternatively you can contact Anisa Keshav from the Human Research Ethics Committee 
  
151
Office at the University of Witwatersrand on (011) 717-1234 or you can email her at 
anisa.keshav@wits.co.za. 
Thank you for your time and interest. 
Yours faithfully, 
Trusha Solanki 
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Consent Form: 
 
I consent to participate in this study. I have received, read and understood the above-
mentioned information and understand the nature, risks and purpose of this study. 
 
I have been informed of the fact that the results of this study will be included in a 
research report but it will not contain any identifying information. I have also had 
sufficient opportunity to ask questions. 
 
I agree to participate voluntarily and understand that I may refuse to answer any 
particular questions or withdraw from the study at any time without any negative 
consequences/penalties. 
 
I have had sufficient opportunity to ask questions and of my own free will declare myself 
prepared to participate in this study.  
Name of Participant: _____________________________ Date: ____________________ 
Signature: ______________________________________ 
 
Researcher 
 
I here within confirm that the above participant has been fully informed about the nature, 
conduct and risks of the research study on “The Prevalence of Hearing Loss in Older 
Adults Presenting with Cardiovascular Disease” 
 
Name of Researcher: _____________________________ Date: ____________________ 
 
Signature: ______________________________________ 
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Appendix C:  Data collection forms (results for basic test battery and form utilized 
to record otoacoustic emission results) 
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OTOACOUSTIC EMISSION (OAE) REPORT 
Patient name: ________________________________ 
Date of Birth: ________________________________ 
Ear: ________________________________________ 
Type of OAE: ________________________________ 
Protocol: ____________________________________ 
 
Results: 
 
 Right Ear 
 750Hz 1000Hz 2000Hz 3000Hz 4000Hz 6000Hz 8000Hz 
OAE  
(dB) 
       
Noise Floor 
(dB) 
       
Pass/fail        
 
 Left Ear 
 750Hz 1000Hz 2000Hz 3000Hz 4000Hz 6000Hz 8000Hz 
OAE  
(dB) 
       
Noise Floor 
(dB) 
       
Pass/fail        
 
 
Comments: 
_____________________________________________________________
_____________________________________________________________ 
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Appendix D:  Ethical clearance certificate from the Human Research Ethics 
Committee (Medical) at the University of Witwatersrand 
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Appendix E:  Letter of permission from Charlotte Maxeke Johannesburg 
Academic Hospital 
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Appendix F:  Letters of permission from South Rand Hospital 
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Appendix G:  Template of report provided to participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
165
SOUTH RAND HOSPITAL 
Audiology Department 
 
Name: ______________________________ Date: ___________________ 
Date of Birth: ________________________ Age: ____________________ 
Examiner: ___________________________ Referred by: _____________ 
Diagnosis: ____________________________ 
 
Case History: ___________________________________________________________ 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
Otoscopic Examination 
Right Ear: _______________________________________________________________ 
Left Ear: ________________________________________________________________ 
 
Immittance Audiometry 
Right Ear: ______________________________________________________________ 
                   ______________________________________________________________ 
Left Ear: ________________________________________________________________ 
                  _______________________________________________________________ 
 
Pure Tone Audiometry 
Right Ear: ______________________________________________________________ 
                   ______________________________________________________________ 
Left Ear: ________________________________________________________________ 
                  _______________________________________________________________ 
 
PTA: Right Ear _________________________ Left Ear __________________________ 
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Speech Audiometry 
Right Ear: ______________________________________________________________ 
                   ______________________________________________________________ 
Left Ear: ________________________________________________________________ 
                  _______________________________________________________________ 
 
DPOAEs 
Right Ear: ______________________________________________________________ 
                   ______________________________________________________________ 
Left Ear: ________________________________________________________________ 
                ________________________________________________________________ 
 
Summary of Results 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
Recommendations 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
If you have any questions, or require further information, do not hesitate to contact me on 
083 455 7770. 
Thank you, 
____________________ 
T. Solanki 
Speech Therapist & Audiologist 
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Appendix H:  Certificates of calibration of equipment 
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